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Abstract
The decision for a bacterium to grow and divide may seem like a simple process,
but in reality, there are many factors that influence and regulate this choice. Bacteria
have been known to respond to many environmental signals or cues that represent either
favorable or non-favorable growth conditions, as well as cues, secreted from other
bacteria or, in the case of a pathogen, the host. It is not uncommon for bacteria that find
their environment unfavorable, to alter their growth, and in some cases, even enter into
a type of non-proliferative state, which we term, dormancy. Bacterial dormancy has
many advantages that allow cells to survive times of hardship.
In Manuscript I, I review different strategies bacteria use to enter into and exit
from dormancy, while comparing three well-studied organisms, Bacillus subtilis,
Mycobacterium tuberculosis and uropathogenic Escherichia coli (UPEC). I further
highlight the mechanisms in which bacteria regulate their preferred method of dormancy
and specific signals or cues utilized by bacteria to stimulate their resurgence.
Additionally, I discuss aspects of bacterial dormancy that may be targeted for novel
therapeutics.
In Manuscript II, we further characterize UPEC dormancy. We show that
quiescence is prevalent amongst clinical UPEC isolates tested, where 35% (51/145)
enter into a non-proliferative state, including several isolates from the problematic
multidrug-resistant pandemic lineage ST131. We report quiescent cells as being
filamentous, with a population of cells containing one or more incomplete septa,
implying a cell division defect. UPEC quiescence is quorum-dependent and we report,

for the first time, that specific peptidoglycan fragments, serving as cues, stimulate
UPEC resuscitation.
In Manuscript III, we characterize the enzymatic activity of the cell division
regulator, ZapE and report the first evidence suggesting that ZapE behaves as a FtsZ
polymer bundler, in vitro. We further show that ZapE is a positive regulator of UPEC
quiescence and demonstrate that optimal enzymatic function of ZapE is required for the
entrance into and/or maintenance of the quiescent state, as described in the Appendix.
In conclusion, this work as a whole, has furthered our knowledge pertaining to
ZapE as an E. coli cell division regulator, elucidated novel cues utilized by UPEC to
stimulate resuscitation out of dormancy, and, in general, has greatly advanced our
understanding of bacterial quiescence and proliferation.
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PREFACE
This dissertation has been prepared in the Manuscript Format according to the
guidelines set forth by the Graduate School of the University of Rhode Island.
Manuscript I, “Regulation of bacterial dormancy: entrance into and exit from a nonreplicating state” is formatted as a review article for Frontiers in Microbiology.
Manuscript II, “Peptidoglycan sensing prevents quiescence and promotes quorumindependent colony growth of uropathogenic Escherichia coli” was published in
Journal of Bacteriology in 2020. Manuscript III, “Characterization and function of the
Escherichia coli cell division regulator ZapE” was formatted and will be submitted to
Journal of Bacteriology for publication.
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Abstract
Bacteria encounter many environmental factors that influence their decision to
grow and divide. In response to these factors, some bacteria enter into a dormant or nonreplicating, but reversible state, allowing a bacterium to survive stresses, such as
nutrient deprivation, environmental stresses (i.e. pH, UV and temperature) and in the
case of a pathogen, the host immune response. Entering a dormant state, however, poses
challenges for a bacterium, especially when the bacterium exists in a complex
community. Dormancy may also confer a higher level of antibiotic tolerance often
termed phenotypic antibiotic resistance and currently serves as a major challenge for
effective therapeutics. Here, we will evaluate several dormant states among bacteria and
discuss known strategies that bacteria use to enter and exit a dormant state. We will
highlight three well-studied organisms, Bacillus subtilis, Mycobacterium tuberculosis
and uropathogenic Escherichia coli, and compare their strategies for controlling
dormancy. We will further discuss potential mechanisms for bacteria to control
proliferation at the physiological level, through regulation of the cell division pathway
or other essential cellular pathways, and describe how these pathways may be targeted
for novel therapeutics.

Introduction
Bacterial dormancy provides an evolutionary advantage for cells to survive
many types of stress (Rittershaus et al., 2013). Environmental conditions encountered
by a cell during its life cycle are subject to constant flux and the minimum necessities
for growth (i.e., nitrogen, carbon, phosphorus and water) are not always present
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(Rittershaus et al., 2013). Bacteria, as a result, have developed different methods to
survive during these nutrient limiting or detrimental periods. In this review, we will
outline the major mechanisms underlying bacterial dormancy (i.e., sporulation and
quiescence) in the model organisms Bacillus subtilis and Mycobacterium tuberculosis
(Stragier and Losick, 1996; Wayne and Hayes, 1996a; Cunningham and Spreadbury,
1998; Errington, 2003; Eoh and Rhee, 2013; Gopinath et al., 2015) and also highlight
the recently discovered state of quiescence uropathogenic E. coli (UPEC) (LeathamJensen et al., 2016; Sun et al., 2019; DiBiasio et al., 2020). Here, we discuss how
bacteria enter into and exit from dormancy and compare key differences between
quiescence and sporulation. Many human pathogens enter into a dormant state, and we
will discuss several examples of therapeutic treatments complicated by bacterial
dormancy (Mitchison, 2004; Mysorekar and Hultgren, 2006). Lastly, we will highlight
potential aspects of bacterial dormancy that may serve as a target for novel therapeutics.

Sporulation
Under harsh conditions certain bacteria, including those of the genus
Clostridium and Bacillus, possess the ability to form specialized metabolically inactive
cells called endospores in a process called sporulation (Stragier and Losick, 1996;
Errington, 2003). Endospores in several pathogenic bacteria are important for
establishing infection in humans. For example, Bacillus anthracis (B. anthracis), the
causative agent for the disease anthrax, relies on spores being the infectious agent and
not vegetative cells, which have been shown to be noninfectious in animal models
(Mock and Fouet, 2001). Clostridium difficile (C. difficile), a major pathogen associated
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with causing nosocomial infections, diarrhea, and colitis, relies on the generation of
spores as the main morphotype for transmission and infection given its strict anaerobic
necessities to form vegetative cells (Paredes-Sabja et al., 2014).

The method in which an endospore is created is very unusual (Fig. 2).
Sporulation begins with sensing a change in the environment leading towards
asymmetric cell division, accompanied by engulfment of a smaller forespore or prespore
by its larger sporangium or mother cell sibling (Errington, 2003). The success of the
endospore is attributed to the sacrifice of the mother cell, which utilizes all of its energy
and resources in creating a prespore that contains multiple layers of protection to
increase the chances of survival by the mature endospore (Errington, 2003). The hardy
endospore can survive extreme temperatures, detergents, hydrolytic enzymes, chemical
solvents and radiation, conditions that would typically kill most bacteria (Nicholson et
al., 2000).

Bacillus subtilis
The condition that initiates sporulation is starvation (Errington, 2003; Ochi et
al., 1981), in conjunction with population density or quorum sensing (Fuqua et al., 1996)
(Fig. 1). Identification of different stimuli, such as surfactin, the ComX pheromone, or
small peptides, which are secreted by actively growing cells and accumulate in the
culture medium, induce a response once a threshold is reached, usually at high cell
density (Magnuson et al., 1994; Lazazzera et al., 1997; Hamoen et al., 2003; Ohsawa et
al., 2006; López et al., 2010) Two major sporulation pentapeptides (ERGMT and
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ARNQT) have been identified as cell-cell signaling molecules in Bacillus subtilis and
uptake requires an oligopeptide permease encoded by spo0K (opp) (Solomon et al.,
1995, 1996, 2003; Lazazzera et al., 1997). This finding demonstrates uptake of specific
pentapeptides, through Opp, is necessary to stimulate sporulation (Lazazzera et al.,
1997). Once inside, the signaling peptides interact with specific phosphatases (Rap
proteins), where, for example, binding leads towards the dephosphorylation of
phosphorylated Spo0F. Spo0F servers as an intermediate response regulator of the
sporulation phosphorelay system (Perego, 1997; Jiang et al., 2000a; Ishikawa et al.,
2002). Accordingly, the phosphorelay system continues resulting in the phosphorylation
of Spo0B, which ultimately is used to phosphorylate the DNA-binding protein Spo0A
(Jiang et al., 2000a; Lazazzera, 2000; Molle et al., 2003). In its active state, Spo0A,
serves as the master transcriptional regulator of sporulation, where it regulates over 100
genes and operons, including genes involved with DNA initiation and cell division
(Gholamhoseinian et al., 1992; Gonzy-Tréboul et al., 1992; York et al., 1992; BenYehuda and Losick, 2002; Molle et al., 2003; Simpson et al., 2016).

In addition, B. subtilis carries genes encoding specific sensor kinases (i.e. kinA,
kinB, kinC, kinD and kinE) that play a role in recognizing environmental stress and then
feed phosphoryl groups into the sporulation inducing phosphorelay system, further
leading toward the activation of the response regulator Spo0A (Burbulys et al., 1991;
Hoch, 1993a, 1993b; Jiang et al., 2000b, 2000a; Serra et al., 2014). Under nutrient
limiting conditions, such as a decrease in the availability of amino acids or a carbon
source, the stringent response is activated and results in the conversion of available GTP
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into the alarmone (p)ppGpp, leading to a decrease in intracellular GTP levels (Cashel,
1996). This decrease inactivates the repressor of sporulation and stationary phase genes,
CodY (Slack et al., 1993; Serror and Sonenshein, 1996). Inactivation of CodY, the
release of repression by the transition state regulator AbrB, and production of sigma H
(σH), leads towards stimulation of KinA production that ultimately produces an increase
in phosphorylated Spo0A (Weir et al., 1991; Sonenshein, 2000). Further, the other
sporulation related sensory kinases respond to a variety of different stimuli, for example,
KinB has been shown to respond to a block in respiration (Kolodkin-Gal et al., 2013),
while KinC has been shown to be activated by a decrease in membrane potential and
potassium leakage (López et al., 2009; Shemesh et al., 2010). Additionally, KinD
appears to be activated by an increase in extracellular matrix (Aguilar et al., 2010;
Rubinstein et al., 2012), and KinE regulates Spo0A phosphorylation during biofilm
conditions (Jiang et al., 2000b; Hamon and Lazazzera, 2001).

Overall, the mechanism by which spore forming bacteria regulate entry into
dormancy is multifaceted and complex (Fig. 1). A key aspect of sporulation is the
heterogeneity or phenotypic variability that aligns with variable signaling activities. In
part, the heterochronic nature of sporulation, exhibited through altered sporulation
timing resulting in an asynchronous population, is due to the variability in
phosphorylated levels of Spo0A generated by altered signaling controlled by multiple
phosphatases and kinases in the multicomponent phosphorelay system (Perego et al.,
1994; Jiang et al., 2000b; Veening et al., 2008; Bischofs et al., 2009; Chastanet et al.,
2010; de Jong et al., 2010; Levine et al., 2012; Mutlu et al., 2018). The benefit of cell
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heterogeneity, exemplified by spore forming bacteria, is that having multiple cell types
acts as a bet-hedging strategy to ensure survival of a subpopulation of organisms in the
community (Veening et al., 2008; Setlow et al., 2012; Ackermann, 2015; Grimbergen
et al., 2015).

During sporulation, as the forespore matures, the mother cell engulfs the
forespore and uses its cytoplasm as the spore core (Stragier and Losick, 1996; Piggot
and Hilbert, 2004). The cell division pathway actively participates in the separation, but
is modified and tightly regulated during early sporulation (Fig. 2). Two ring-like
structures, termed Z-rings, comprised of the tubulin homologue FtsZ, which
polymerizes when bound to GTP, are established at two near-polar regions of the cell,
instead of the normal midcell position, as the chromosome replicates and the cell
elongates (Errington, 2003). The unique orientation and formation of the Z-rings is due
to a slight upregulation of ftsZ synthesis, directed by Sigma H (σH) activation, and
through the production of SpoIIE, which is regulated by Spo0A (Gholamhoseinian et
al., 1992; Gonzy-Tréboul et al., 1992; York et al., 1992; Ben-Yehuda and Losick, 2002).
SpoIIE is a dual-function protein, that contributes to the activation of Sigma F (σF) in
the forespore and has been shown to interact directly with FtsZ; however, the exact
functional role for the FtsZ interaction remains unclear (Duncan et al., 1995; Arigoni et
al., 1996; Feucht et al., 1996; Lucet et al., 2000). The chromosome elongates into a
structure termed the axial filament, that extends the full length of the cell, which is
thought to contribute to the block in midcell division (Ryter, 1965; Bylund et al., 1993).
Although two Z-rings form during early sporulation, only one Z-ring results in a proper
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septum (Errington and Wu, 2017). Production of σF in the forespore activates genes
linked to further spore development. One of these genes, spoIIR, serves as a cross
regulatory factor, that activates the expression of Sigma E (σE) in the mother cell (Karow
et al., 1995). SpoIIR further activates transcription of mciZ, which produces a protein,
MciZ, that inhibits FtsZ assembly (Handler et al., 2008). MciZ antagonizes FtsZ
polymerization, thus preventing Z-ring formation, by capping the minus end of FtsZ
polymers and sequestering FtsZ subunits (Bisson-Filho et al., 2015). During
sporulation, MciZ also plays a role in preventing constriction of the secondary Z-ring
localized in the mother cell partition (Errington and Wu, 2017). Additionally, σE
induces the expression of spoIID, spoIIM and spoIIP, which further prevents unwanted
polar division in the mother cell and supports ultimate forespore engulfment
(Eichenberger et al., 2001). After segregation, the cortex is synthesized around the spore
core comprising of mainly peptidoglycan and is required for spore dehydration and
dormancy (Vasudevan et al., 2007). Following the formation of the cortex, an outer
layer comprised of a thick multifaceted proteinaceous coat comprise of at least 70
different proteins is deposited (McKenney and Eichenberger, 2012; Segev et al., 2012),
where the formation of a crust on top of the spore coat marks the final developmental
aspect of a mature spore (McKenney et al., 2010; Bartels et al., 2019). After spore
maturation, the mother cell lyses through digestion of its peptidoglycan layer by
autolysin activity and results in the release of the endospore into the environment (Smith
and Foster, 1995; Tan and Ramamurthi, 2014). The complete process of sporulation,
generation of a mature endospore and consequential release, takes approximately 8
hours (Stragier and Losick, 1996; Piggot and Hilbert, 2004) (Fig. 2).
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Following the sporulation process resulting in a mature endospore, the
endospore can convert back into an actively growing or dividing cell through a method
termed germination. This process involves rehydration of the spore, cortex hydrolysis,
and coat disassembly (Setlow, 2003). Like sporulation, germination, is heterochronic in
nature as described by phenotypic variability due to variance in signaling activities,
resulting in an asynchronous population, and partially, this variability can be attributed
to different levels in production of germinant receptors (Rosenberg et al., 2015; Sinai et
al., 2015; Sturm and Dworkin, 2015; Mutlu et al., 2018). Specific germinants or cues
include sugars (i.e., glucose and fructose), amino acids and peptidoglycan derived
muropeptides (Fig. 1). These germination factors can bind to receptors displayed in the
inner endospore membrane acting as a signal that results in the spore’s resurgence
(Kanda et al., 1991; Setlow, 2003; Moir, 2006; Shah et al., 2008; Shah and Dworkin,
2010).

The B. subtilis integral membrane protein receptors GerAA/AB and putative
lipoprotein GerAC are required for germination and respond to the amino acid Lalanine. The receptors are located in the inner membrane of the endospore where they
respond to cues that are able to penetrate the hearty outer layers (Hudson et al., 2001;
Paidhungat and Setlow, 2001). Among spore forming bacteria, there are variations in
the exact chemical nature of the cues and interestingly even though most cues are
classically nutrients, they are not metabolized (Shah et al., 2008). For example, Lalanine or a mixture of fructose, glucose, asparagine and potassium ions both stimulate
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germination in B. subtilis, while the amino acid, L-proline, germinates Bacillus
megaterium endospores, and a combination of several amino acids can function as cogerminants for the pathogen B. anthracis (Setlow, 2003). Further, various amino acids
serve as germinants and co-germinants for several Clostridium species, including C.
difficile (Alberto et al., 2003; Paredes-Sabja et al., 2008; Bhattacharjee et al., 2016;
Brunt et al., 2016; Kochan et al., 2017, 2018).

Excitingly, it has been reported that muropeptides released from actively
growing bacteria, can serve as cues to act as germination factors for B. subtilis
endospores (Shah et al., 2008). Specificity lies in the third position of the peptide stem
of peptidoglycan where m-Dpm (meso-diaminopimelic acid), rather than L-lysine, acts
as the molecular determinant required to stimulate a response (Shah et al., 2008). The
muropeptide receptor is a membrane associated serine/threonine kinase, PrkC, and
contains an extracellular penicillin-binding protein and serine/threonine kinase
associated (PASTA) sensory domain, which interacts directly with the peptidoglycan
fragments and likely autophosphorylates itself and phosphorylates elongation factor G
(EF-G), an essential GTPase engaged in tRNA and mRNA translocation (Gaidenko et
al., 2002; Savelsbergh et al., 2003; Shah et al., 2008). The binding of peptidoglycan
fragments by PrkC and the interaction between PrkC and EF-G has been hypothesized
to stimulate translation, since spores still possess polysomes and mRNA, and thus aid
in germination of the spore (Setlow and Kornberg, 1970; Shah et al., 2008).
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Quiescence
In order to define bacterial quiescence, we will start with the well-established
archetypal example of quiescence represented by the genus Mycobacterium, while the
newly discovered UPEC quiescence will be discussed later in this review. If we define
bacterial dormancy as a reversible non-replicating state, then there are many similarities
between endospores and quiescent cells. However, quiescent cells are distinct from
spores mainly due to the lack of major morphological differentiation.

Mycobacterium tuberculosis

Dormant Mycobacterium are bacilli that are non-replicating and develop an
altered phenotype (i.e., elongated) in comparison to actively replicating cells (Wayne
and Hayes, 1996a; Cunningham and Spreadbury, 1998; Chauhan et al., 2006; Eoh and
Rhee, 2013; Gopinath et al., 2015). However, these dormant cells are quite distinct from
endospores. Unlike endospores, quiescent cells preserve their membrane potential, do
not undergo drastic morphological change and maintain minimal metabolic capacity
(Wayne and Hayes, 1996a; Cunningham and Spreadbury, 1998; Rao et al., 2008;
Gengenbacher et al., 2010; Eoh and Rhee, 2013; Gopinath et al., 2015).

M. tuberculosis, the causative agent of tuberculosis (TB) in humans, is widely
studied and will serve as our model organism for the genus Mycobacterium. TB
infection is caused by inhalation of droplets containing M. tuberculosis aerosolized via
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coughs and sneezes. Once inhaled, M. tuberculosis can infect the phagocytic immune
cells, including macrophages, allowing the bacteria to replicate within, and then spread
to pulmonary lymph nodes and additional pulmonary sites before the adaptive immune
system responds (Teitelbaum, 1999; Ryndak et al., 2015). During this process, M.
tuberculosis can be destroyed by the host immune system, multiply leading towards
primary infection, avoid host clearance through the establishment of a dormant state and
reactivate previously established dormant bacteria by infringement, thus causing
another infection (Trauner et al., 2012).

M. tuberculosis dormancy can further be characterized by phenotypic antibiotic
resistance, and therefore antibiotic tolerance (i.e., rifampicin (RIF), a DNA-dependent
RNA polymerase inhibitor and isoniazid (INH) a mycolic acid synthesis inhibitor)
(Quemard et al., 1991; Campbell et al., 2001; Gengenbacher and Kaufmann, 2012). TB
chemotherapy usually lasts 6 to 9 months, and 90% of actively replicating M.
tuberculosis cells are typically killed after 3 to 4 weeks, with the remainder of time
targeting dormant cells (Chao & Rubin, 2010; Koul et al., 2011). Dormant M.
tuberculosis become sensitive to most antibiotics and the host immune system only after
cells are stimulated to actively grow and divide (Chao & Rubin, 2010; Koul et al., 2011).

M. tuberculosis enters into a dormant state, in vitro, under low levels of oxygen
(Wayne and Hayes, 1996b; Dick et al., 1998), similar to hypoxic conditions that trigger
dormancy in the fibrotic granulomatous lesions in the lung (Wayne, 1994; Wayne and
Sohaskey, 2001; Boshoff and Barry, 2005) (Fig. 3). During dormancy, M. tuberculosis
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cells go through physiological changes, for example: cell-wall thickening (Cunningham
and Spreadbury, 1998), cell-wall alterations indicated by negative results on acid-fast
staining (Seiler et al., 2003), formation of lipid bodies (Rodríguez et al., 2014) and a
high percentage (80%) of peptidoglycan stem 3"3 cross-links generated by L,Dtranspeptidation during stationary phase (Lavollay et al., 2008); however, these
phenotypic changes are minor overall compared to sporulation (Rittershaus et al., 2013).

Interestingly, central carbon metabolism during M. tuberculosis dormancy was
not significantly altered in comparison to other metabolic processes (Gopinath et al.,
2015), while some enzymes at the entry point of the tricarboxylic acid (TCA) cycle,
pyruvate dehydrogenase and citrate synthase, and an enzyme in the glyoxylate shunt,
isocitrate lyase, used by M. tuberculosis to increase production of succinate, were all
up-regulated (Gopinath et al., 2015). One of the main proteins being expressed during
M. tuberculosis dormancy is alpha-crystallin chaperone protein (Acr) (Cunningham and
Spreadbury, 1998; Mayuri et al., 2002). Acr protein expression during dormancy was
up-regulated 225-fold during the microaerophilic stage (day 8 through day 14, postoxygen depletion) and 246-fold during the anerobic stage (past day 14) showing an
increase in expression over time (Gopinath et al., 2015). In M. tuberculosis, cell wall
thickening was strongly associated with an increase in Acr when dormant cells were
induced by low oxygen tension suggesting a potential link and overall role in regulation
of M. tuberculosis dormancy (Cunningham and Spreadbury, 1998). In addition, Clp
proteases assist in the transition of M. tuberculosis into dormancy, and play a role in M.
tuberculosis viability, as they actively degrade misfolded proteins that accumulate
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during stress (Raju et al., 2012). For example, in M. tuberculosis, ClpX, an AAA+
ATPase that serves as the substrate recognition portion of the ClpXP protease, levels
were up during the entry into quiescence (Jenal and Fuchs, 1998; Gottesman, 2003;
Frees et al., 2007; Gopinath et al., 2015).

B. subtilis carries specific sensory kinases to recognize environmental stress and
induce sporulation. There are similarities with M. tuberculosis, as they also use sensory
kinases to detect unfavorable environmental conditions leading to the induction of a
dormant state (Fig. 3). For example, the two-component system (TCS) DosR/DosS,
comprised of a heme-containing sensor histidine kinase DosS/DosT, with regulatory
ligands O2, NO and CO (Kumar et al., 2007), and a DNA-binding protein DosR, that is
induced under hypoxia, or in response to NO production from host macrophages, and is
one of the major regulators of M. tuberculosis dormancy (Bretl et al., 2011; Bhat and
Yaseen, 2018). DosR is a transcription factor that mediates M. tuberculosis dormancy
through activating roughly 50 genes, in the DosR regulon, including the nitrate
reductase pathway, universal stress proteins, transporter proteins and a ~80-fold
induction of acr (Park et al., 2003; Hu et al., 2006). In M. tuberculosis, the DosR regulon
has been shown to comprise approximately 20% of all proteins produced after 20 days
under anaerobic conditions (Schubert et al., 2015); however, most genes in the DosR
regulon have unknown functions (Hu et al., 2006).

Nutritional limitation (i.e. carbon, nitrogen and phosphorous) has also been
linked to Mycobacterium dormancy and long term survival, which has been thought to
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mimic the limited nutrient availability in human granulomas (Smeulders et al., 1999;
Betts et al., 2002; Lipworth et al., 2016; Kumar et al., 2017) (Fig. 3). Gene expression
profiling of nutrient-starved M. tuberculosis revealed an increase in expression of the
stringent response, specifically relMtb, which is the enzyme in M. tuberculosis that
synthesizes ppGpp, and sigma factor E (σE) that acts as a subunit of RNA polymerase
that guides the polymerase to promoters of stress-resistant genes, leading toward a
phenotypic shift to a more stress-resistant state. In contrast, there was a decrease in
expression of genes associated with translation, cell division, lipid biosynthesis and
aerobic respiration during the same nutrient starved conditions previously tested (Betts
et al., 2002). Further genes involved with metabolism and amino acid biosynthesis (ald,
alanine dehydrogenase and frdA, fumarate reductase) were upregulated, and may aid in
the survivability of M. tuberculosis under nutrient limiting conditions (Betts et al.,
2002).

Interestingly, during and throughout M. tuberculosis infection inside guinea pig
lung granulomas, expression of dormancy genes dosR and acr and the critical cell
division gene, ftsZ, are detected, as well as their protein products (Sharma et al., 2006).
During growth in macrophages, M. tuberculosis displays a filamentous phenotype
(Chauhan et al., 2006). Subsequent experiments to visualize FtsZ by fluorescence
microscopy showed an extremely low frequency of Z-rings in macrophages and the
majority of elongated cells demonstrated a spiral-like FtsZ orchestration throughout the
entire length of the cell (Chauhan et al., 2006). These observations suggest a link
between M. tuberculosis division regulation and infection survivability in the host.
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Like endospore germination, quiescent mycobacterium can be stimulated to exit
dormancy, reestablish metabolic activity, and re-enter the growth cycle. This initiation
of regrowth in Mycobacterium is termed resuscitation (Gengenbacher and Kaufmann,
2012) (Fig. 3). Resuscitation can be induced by specific resuscitation-promoting factor
(Rpf), first identified from Micrococcus luteus, which has been identified to be an antidormancy factor (Mukamolova et al., 1998; Cohen-Gonsaud et al., 2005). Five rpf genes
(A to E) have been identified in M. tuberculosis to contain the Rpf domain, which has
strong structural homology to lysozyme and other lytic transglycosylases and cleaves
peptidoglycan (Cohen-Gonsaud et al., 2004, 2005; Ravagnani et al., 2005; Keep et al.,
2006; Mukamolova et al., 2006).

The specific mechanisms for regulating Rpf proteins are unclear; however, some
insight has been gained from M. tuberculosis. During starvation, a cyclic AMP receptorlike transcription factor has been show to activate RpfA during starvation (Rickman et
al., 2005). Other regulators have also been proposed to control expression of Rpf,
specifically RpfC, as in SigD, the stringent response and RelA (Dahl et al., 2003; Raman
et al., 2004). Moreover, Rpf have been hypothesized to require a protein-protein
interaction in order to become functional shown by an interaction at the septum between
RpfB and an endopeptidase, which is essential for proliferation (Hett et al., 2007).
Further, a peptidoglycan hydrolase, RipA, has been shown to interact with RpfB and
RpfE (Stahl and Urbance, 1990).
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As previously stated, dormant M. tuberculosis go through phenotypic changes
including cell wall modifications, an increase in peptidoglycan stem 3"3 cross-links
and thickening (Cunningham and Spreadbury, 1998; Seiler et al., 2003; Lavollay et al.,
2008). Interestingly, this suggests that the role of Rpf in resuscitation of quiescent cells
involves hydrolysis of peptidoglycan, either by releasing peptidoglycan fragment cues
or inducing a structural change in peptidoglycan to facilitate new cell wall (Keep et al.,
2006; Hett and Rubin, 2008). For cells to re-enter the growth cycle, the cell wall needs
to be broken down and new peptidoglycan monomers inserted; this is achieved by
essential peptidoglycan specific hydrolytic enzymes.

Peptidoglycan muropeptide fragments are known to resuscitate dormant
Mycobacterium smegmatis (M. smegmatis), one of the model mycobacteria, which is
generally non-pathogenic and “fast growing” (Rybniker et al., 2006; Rahman et al.,
2014; Melief et al., 2018). The minimum unit capable of stimulating resuscitation is a
synthetic

1,6-anhydrodisaccharide-dipeptide

(N‐acetylglucosaminyl‐β(1→4)‐N‐

glycolyl‐1,6‐anhydromuramyl‐L‐alanyl‐D‐isoglutamate) (Nikitushkin et al., 2015;
Ealand et al., 2018). Peptidoglycan fragment cues may stimulate a response upon
recognition by specific receptors. For example, PknB, in M. tuberculosis, is a
serine/threonine protein kinase (STPK) that plays an important role in cellular signaling
and has been linked to different aspects of cell division, cycle progression and growth.
(Jones and Dyson, 2006). PknB is a transmembrane protein with an extracellular Cterminal (PASTA) sensory domain and an intracellular kinase domain (Yeats et al.,
2002). The PASTA domain of PknB has been shown to bind to unlinked stem
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peptidoglycan peptides. These findings suggest PknB may be able to bind to
peptidoglycan fragments released by Rpf hydrolysis, and as a result, trigger
resuscitation of quiescent cells (Jones and Dyson, 2006; Hett and Rubin, 2008).

In addition to the five Rpf proteins, the DosR regulon has been linked to M.
tuberculosis resuscitation after transition from anaerobic to aerobic conditions, where
expression levels of genes under its control significantly alter (Leistikow et al., 2010;
McGillivray et al., 2015). Clp proteases have been linked to resuscitation of M.
tuberculosis in addition to quiescence entry. Notably, the transcriptional regulator of the
clp operon, clgR, is required for resuscitation of hypoxia induced quiescent cells
(McGillivray et al., 2015).

Uropathogenic Escherichia coli

UPEC have also been shown to enter into a quiescent, non-proliferative state in
pure culture, as well as during infection in vivo (Mysorekar and Hultgren, 2006;
Leatham-Jensen et al., 2016; Sun et al., 2019; DiBiasio et al., 2020). UPEC are the
leading cause of uncomplicated urinary tract infections (UTIs) (Silverman et al., 2013).
The annual cost on the United States health care system from UPEC infections exceeds
two billion dollars (Foxman, 2010). A hallmark of UPEC is its ability to invade and
colonize bladder epithelial cells and once inside UPEC form intracellular biofilm-like
communities (IBCs) and can problematically enter into a quiescent state in endosomal
vesicles, forming quiescent intracellular reservoirs (QIRs) (Kerrn et al., 2005;
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Mysorekar and Hultgren, 2006; Rosen et al., 2007; Silverman et al., 2013). During
infection, quiescent cells are more resistant to the host immune response, less sensitive
to antibiotics, and are believed to be the primary cause for recurrent UTIs (Kerrn et al.,
2005; Silverman et al., 2013). Recurrent UTIs affect 10 to 40% of women whom have
recently recovered from an initial UTI (Hooton, 2001), and it has been estimated that
up to 77% of those cases result from the same UPEC strain that caused the initial
infection (Russo et al., 1995; Ejrnaes et al., 2006).

UPEC enter into a non-proliferative state when seeded at low density (i.e., ≤106
CFU/mL), but grow robustly at high cell density (i.e., >106 CFU/mL), in glucose
minimal medium, demonstrating that growth is quorum-dependent (Leatham-Jensen et
al., 2016; DiBiasio et al., 2020) (Fig. 4). Quiescence is not limited to glucose as the sole
carbon source, as acetate, N-acetylglucosamine (NAG) or arabinose can also induce
quiescence (Leatham-Jensen et al., 2016), but other carbon sources, including glycerol,
promote proliferation, indicating that the failure to proliferate is not due to a lack of
nutrients or auxotrophy. Additionally, UPEC quiescence is distinct from M. tuberculosis
quiescence, where dormancy is triggered by hypoxia and nutrient limitation (Wayne
and Hayes, 1996b; Dick et al., 1998; Smeulders et al., 1999; Betts et al., 2002; Lipworth
et al., 2016; Kumar et al., 2017). Over 145 clinical UPEC isolates that have been tested
for quiescence at low plating density, 51 strains (35%) enter the quiescent state,
including the worldwide multi-drug resistant ST131 isolate, JJ1886 and the widely
studied model strain CFT073 (Leatham-Jensen et al., 2016; DiBiasio et al., 2020).
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Typically, E. coli cells that are proliferative display a narrow cell length
distribution with an average cell length of around 2.5 μm (Grossman et al., 1982). During
infection, quiescent UPEC typically retain their initial shape and size when they enter
into the host bladder epithelial cell (Mulvey et al., 2001; Eto et al., 2006; Mysorekar
and Hultgren, 2006; Barber et al., 2016). However, inside bladder cells, UPEC have the
ability to establish IBCs that have three distinct cellular morphologies including rods,
spheres and filaments (Mulvey et al., 2001; Anderson et al., 2003; Justice et al., 2004).
One possible advantage of cell filamentation is to increase resistance to the host immune
response by withstanding phagocytosis in the bladder (Justice et al., 2004).
Morphological analysis conducted on quiescent UPEC in culture (i.e., strain CFT073
becomes quiescent at low plating density on glucose minimal agar), showed that
cultured quiescent cell are also filamentous (DiBiasio et al., 2020). After prolonged
incubation, quiescent cells remained filamentous, suggesting that a cell division block
was responsible for the filamentation (DiBiasio et al., 2020). The block could either be
caused by a cell division regulator or a cell wall component that becomes limiting during
quiescence. Interestingly, L-lysine in combination with L-methionine, can serve as a
cue to stimulate quiescent UPEC proliferation (Leatham-Jensen et al., 2016; DiBiasio
et al., 2020). This finding is consistent with limited cell wall component availability,
since

L-lysine

biosynthesis

requires

the

peptidoglycan

component

meso-

diaminopimelate (meso-DAP) (Cirillo et al., 1994).

Quiescent UPEC cells must maintain some metabolic activity, including a
complete TCA cycle, and multiple carbon metabolism genes are essential for quiescence
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(Fig. 4). During a mini-Tn5 transposon mutagenesis screen, 5 genes were identified as
essential for quiescence: 6-phosphogluconate dehydrogenase (gnd), glutamate
dehydrogenase (gdhA), pyruvate kinase I (pykF), glucose-6-phosphate dehydrogenase
(zwf) and the succinate dehydrogenase flavoprotein subunit (sdhA) of succinate
dehydrogenase complex (TCA cycle) (Brandsch and Bichler, 1989; Helling, 1994;
Zhao et al., 2004).

E. coli cell division is regulated through the formation of a large protein complex
at midcell termed the divisome (de Boer, 2010; Lutkenhaus et al., 2012; Tsang and
Bernhardt, 2015). FtsZ polymerizes in the presence of nucleotide and forms a large
complex of filaments called the FtsZ-ring. The FtsZ-ring serves as a scaffold for the
recruitment of multiple cell division proteins and assembly of the mature divisome (Bi
and Lutkenhaus, 1991; Lutkenhaus et al., 2012) (Fig. 5). FtsA, an actin-like like ATPase
binds to FtsZ and serves as a membrane anchor to localize FtsZ polymers to the
membrane (Bork et al., 1992; van den Ent and Löwe, 2000; Pichoff and Lutkenhaus,
2005; Conti et al., 2018). ZipA can also serve as a FtsZ membrane tether given ZipA is
a bitopic inner membrane protein that directly associates with FtsZ. Several cell division
proteins function to promote or antagonize FtsZ polymer formation, which modifies
FtsZ subunit dynamics and exchange in the Z-ring (Fig. 5). These FtsZ-associated
proteins (Zaps) can have a major impact in regulating cell division. Zaps (A-D) have
been shown to stabilize FtsZ polymers and promote bundling, while the most recently
discovered, ZapE, has been proposed to destabilize FtsZ polymers (Mohammadi et al.,
2009; Hale et al., 2011; Durand-heredia et al., 2012; Marteyn et al., 2014; Castillo et al.,
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2016; Schumacher et al., 2017). Last, ClpXP, a two-component proteasome complex,
degrades FtsZ, and regulates FtsZ subunit exchange in the FtsZ-ring through a polymer
severing mechanism (Camberg et al., 2009; Viola et al., 2017).

After the recruitment of early septal FtsZ-ring associated proteins, enzymes that
catalyze peptidoglycan remodeling and synthesis are recruited to the division site during
the late septal phase. The recruitment of FtsN to the divisome may initiate peptidoglycan
remodeling at the septum by activating the FtsBLQ complex, FtsW, which transports
lipid-linked peptidoglycan precursors from the cytoplasm into the periplasm, FtsI, and
other amidases (i.e., AmiC) necessary for septation (Botta and Park, 1981; Addinall et
al., 1997; Heidrich et al., 2001; Gerding et al., 2009; Lutkenhaus, 2009; Choi et al.,
2018). Furthermore, FtsEX, consisting of an integral membrane protein and an ATPase
that directly binds to FtsZ, recruits additional amidases required for cleavage of
crosslinked peptidoglycan during cell septation (Schmidt et al., 2004; Corbin et al.,
2007).

During cell division, DNA is replicated and segregated to separate halves of the
cell to ensure each newly formed daughter cell gets one identical copy of the
chromosome. There are several proteins that interact with DNA and/or FtsZ directly to
prevent FtsZ-ring formation over a nucleoid and thus localize to midcell. SlmA
associates with specific binding sites on DNA and prevents FtsZ polymerization, where
SlmA associated sites are excluded at the replication terminus (Ter) region located at
mid-cell (Bernhardt and De Boer, 2005; Cho et al., 2011; Tonthat et al., 2011).

22

Moreover, MinC, which is a component of the Min system in E. coli, exhibits polar
oscillation in vivo, which is attributable to a direct interaction with MinD (Raskin and
de Boer, 1999). MinC destabilizes FtsZ polymers in vitro, and prevents assembly of the
FtsZ-ring at the poles (Hu et al., 1999; Hu and Lutkenhaus, 2000; Dajkovic et al., 2008;
LaBreck et al., 2019).

There are also positive regulators that guide the divisome toward the Ter region
of the chromosome, for example, by the formation of a Ter linkage (Bailey et al., 2014).
Interestingly, there are two Zaps involved with this linkage. The anchor or chain is
comprised of FtsZ-ZapA-ZapB-MatP-DNA, where MatP is a DNA-binding protein that
binds to sites located in the Ter region (Mercier et al., 2008; Galli and Gerdes, 2010;
Dupaigne et al., 2012; Espéli et al., 2012). Further, FtsK serves as a DNA translocase
that aids in resolution of chromosome dimers and is essential for proper chromosomal
segregation (Liu et al., 1998; Steiner et al., 1999). FtsK, in an ATP dependent manner,
actively re-arranges the chromosome by pumping DNA toward the dif site, a 28 bp
sequence, located in the Ter region, and results in the positioning of the Ter region at
the divisome (Begg et al., 1995; Deghorain et al., 2011; Stouf et al., 2013).

In vitro quiescent UPEC are filamentous resulting from a putative division
block. Fluorescence microscopy to monitor FtsZ-ring assembly and nucleoid
positioning in quiescent cells showed that only 5% of the cells displayed fluorescent
FtsZ-rings (DiBiasio, et al., unpublished). Further, quiescent cell nucleoids were not
properly segregated in the cell filaments. These data suggest that Gfp-FtsZ is not

23

localizing to midcell, and there is a failure to segregate and/or replicate DNA. In
contrast, proliferative UPEC cells are short, rod-shaped cells with FtsZ-rings a midcell
and one or two segregated nucleoids, depending on the cell cycle progress (DiBiasio, et
al., unpublished). Together, these results suggest that assembly and function of the FtsZring, DNA replication, and/or nucleoid segregation are halted during quiescence.

During the establishment of IBCs, there is a subpopulation of cells that display
a filamentous phenotype, which may contribute to resistance to the host immune
response by avoiding phagocytosis in the bladder (Mulvey et al., 2001; Anderson et al.,
2003; Justice et al., 2004). It has been reported that UPEC are filamentous as a result of
SulA expression (Justice et al., 2006; Horvath Jr et al., 2011), which is an inhibitor of
FtsZ-ring formation through blocking FtsZ polymerization, and DamX (Khandige et al.,
2016), which binds peptidoglycan through a SPOR (sporulation-related repeat) domain
(Yahashiri et al., 2015, 2017). Both sulA and damX were independently knocked out of
CFT073 and tested for the ability to regulate the entrance into and/or maintenance of
quiescence. When tested, both deletion strains were capable of quiescence, suggesting
that they are not involved in regulating the quiescent state (DiBiasio, et al.,
unpublished).

Recently, a novel study was performed involving a modified random insertional
transposon mutagenesis screen on CFT073 to probe for regulators of cell division that
could be linked to regulating the quiescent state. In this screen, remarkably, ZapE, was
discovered to be required for quiescence, and through complementation with a
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hydrolysis defective mutant, ZapE(K84A), remained defective for quiescence, thus
implying the enzymatic function of ZapE is critical for the establishment and/or
maintenance of the quiescent state (Appendix). ZapE, is a recently discovered ATPase
that has been proposed to destabilize FtsZ polymers, in an ATP dependent manner in
vitro (Marteyn et al., 2014). The in vitro assays performed were very qualitative in
nature, and the in vivo assays were performed in the common lab strain K-12, which has
been show to lack the ability to enter into quiescence (Leatham-Jensen et al., 2016).
However, the published data did show that the expression of ZapE needs to be tightly
controlled to allow for proper cell division, and a disruption in ZapE levels, whether
overexpression or absence, can lead toward bacterial filamentation (Marteyn et al.,
2014). Potentially, during quiescence, ZapE is modulating FtsZ polymer dynamics, in
an ATP dependent manner, which leads to inhibition of mature septum formation and
division. The cell division block causes cell filamentation as elongation continues,
which ceases in dormancy. Overall, the identification of ZapE as an important
component for establishing quiescence further supports that the cell division pathway is
a key target for regulating the quiescent state.

Like the other dormant states described in this review, UPEC quiescence can be
reversed and cells resuscitated through the addition of specific proliferants, that act as
signals or cues, including L-lysine and L-methionine, L-lysine and L-tyrosine, glycerol,
ribose, xylose, pectic oligosaccharides isolated from cranberry, human urine, spent
culture media, and peptidoglycan derived tetra- and pentapeptides (Leatham-Jensen et
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al., 2016; Sun et al., 2019; DiBiasio et al., 2020) (Fig. 4). Resuscitation of quiescent
UPEC is again measured through the establishment of colony formation.

It is not uncommon for amino acids, sugars or peptidoglycan fragments to serve
as proliferation factors in dormant bacteria. These cues are a good representation of
favorable environmental conditions that a bacterial cell would want to detect. As
previously stated, many spore forming bacteria respond to specific amino acids, sugars
or a combination of both that act as germinates or co-germinates (Hudson et al., 2001;
Paidhungat and Setlow, 2001; Alberto et al., 2003; Paredes-Sabja et al., 2008;
Bhattacharjee et al., 2016; Brunt et al., 2016; Kochan et al., 2017). Specifically,
quiescent UPEC respond to L-lysine in combination with either L-methionine or Llysine and L-tyrosine, where L-lysine is always required (Leatham-Jensen et al., 2016).
In order to elucidate the method in which L-lysine stimulates resuscitation of quiescent
cells, the principle lysine importer, lysP, was deleted in CFT073, and subsequently
challenged with L-lysine in the quiescence assay. CFT073 DlysP demonstrated
quiescence at low cell density but failed to respond to L-Lysine, suggesting L-Lysine
import is necessary for cells to be stimulated to proliferate in the presence of L-Lysine,
and that lysine biosynthesis is reduced in quiescent cells (DiBiasio et al., 2020).

Additionally, muropeptide fragments have been shown to both germinate B.
subtilis endospores (Shah et al., 2008), and resuscitate quiescent M. smegmatis
(Nikitushkin et al., 2013). It is not surprising that specific peptidoglycan fragments can
serve as cues to stimulate resuscitation of quiescent UPEC. During each generation,
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about 45% of the peptidoglycan in E. coli is continuously turned over (Goodell and
Schwarz, 1985; Reith and Mayer, 2011). During this recycling process, 6% to 8% of
peptidoglycan is released and lost into the medium (Goodell and Schwarz, 1985).
Secreted peptidoglycan fragments could act as cues to stimulate proliferation of
quiescent UPEC. For B. subtilis germination specificity lies in the third position of the
peptidoglycan disaccharide stem peptide and in M. smegmatis the minimum
requirement is the disaccharide dipeptide, where sugars (NAG-NAM) must be present
in both cases (Shah et al., 2008; Nikitushkin et al., 2015). Interestingly, in UPEC this is
not the case, where fragments missing the disaccharide and peptides containing either a
L-lysine or m-Dpm, at the third position of the stem, both stimulate resuscitation, as
observed by colony formation (DiBiasio et al., 2020). In addition, there is peptidoglycan
cue specificity in UPEC demonstrated by active peptidoglycan fragments requiring a
peptide length of 4 to 5 amino acids (DiBiasio et al., 2020). Peptidoglycan fragments
also stimulate quiescent CFT073 DlysP cells to proliferate, suggesting the peptide
fragments are not entering the cell through LysP and likely lead to an increase in lysine
biosynthesis. This is supported by the observation that lysine import is critical for
resuscitation of quiescent cells in the presence of lysine. In addition, in B. subtilis, the
Opp import system has been shown to be required for uptake of specific peptides
required to stimulate sporulation (Lazazzera et al., 1997). In UPEC, peptidoglycan stem
tetra and pentapeptides stimulate resuscitation independent of the Opp import system
(DiBiasio et al., 2020). This result indicates the peptides are either imported by a second,
currently unknown, importer or bind to a presently unknown external receptor. Further,
there haven’t been any characterized muropeptide receptor proteins discovered in
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UPEC, similar to the serine/threonine kinase, PrkC, which is important in B. subtilis
germination (Shah et al., 2008). Similar to dormant M. tuberculosis, UPEC may be
going through cell wall modifications during dormancy (i.e. increased peptidoglycan
stem cross-links) and resuscitation of quiescent UPEC may rely on hydrolysis of
peptidoglycan, either from detection of released peptidoglycan fragments acting as a
cue or structural changes in peptidoglycan allowing for eventual cell division and
growth.

Targeting dormancy as an antibacterial strategy

Throughout this review we have demonstrated the prevalence of bacterial
dormancy amongst multiple genera. Each genus listed contains examples of human
pathogens that utilize dormancy to their benefit for pathogenesis. There have been
multiple examples of dormant bacteria being more tolerant to antibiotic treatment, given
the changes cells undergo during dormancy, and the fact that most antibiotics target
actively growing cellular mechanisms (Levin and Rozen, 2006; Coates and Hu, 2008;
Hurdle et al., 2011). Most antibiotics target 5 major biosynthetic pathways:
peptidoglycan synthesis, folic acid synthesis, DNA replication, transcription, and
protein translation, and these pathways are active during cellular growth (Chopra et al.,
2002). A potential strategy in targeting quiescent bacteria would be disrupting the
cellular membrane proteins that are essential for membrane function. In terms of energy
metabolism and the cell membrane, an example of an effective therapeutic with this
approach is pyrazinamide (PZA) used to treat TB infection. PZA has been shown to
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disrupt the pH in cells, where pH is a key piece in the generation of the proton motive
force used for ATP synthesis. However, PZA is still limited as it requires low levels of
oxygen and acidic pH to be effective in killing Mycobacterium (Zhang et al., 2003;
Wade and Zhang, 2004). A second approach, and a more effective agent, would be
TMC207, used again to treat TB. TMC207 is a diarylquinoline that directly binds to the
conserved subunit C of F0F1-ATPase in mycobacteria (Koul et al., 2008). TMC207
binding blocks the rotational motor movement of the enzyme which disrupts coupled
ATP biosynthesis through preventing proton translocation (Andries et al., 2005).

In addition to developing novel therapeutic to target and kill quiescent bacteria,
methods for targeting dormant bacterial spores are increasingly more challenging. The
most challenging aspect of the endospore is the spore itself which is extremely resistant
to hydrolytic enzymes, chemical solvents detergents, elevated temperatures, and
radiation, as previously stated (Nicholson et al., 2000). Thus, a promising strategy for
killing endospores, that would also be effective in killing quiescent bacteria, would be
to first wake them up, and then challenge with traditional antibiotics. This idea was first
reported by Seidi and Jahanban-Esfahlan, were they proposed delivering Rpf to dormant
M. tuberculosis in combination with traditional antibiotics (Seidi and JahanbanEsfahlan, 2013). This concept could also be applied to all three model organisms B.
subtilis, M. tuberculosis, and UPEC where peptidoglycan hydrolases, peptidoglycan
fragments or specific nutrients (i.e. amino acids and sugars) could be delivered to
dormant bacteria in combination with standard antibiotic treatment. An example of this
strategy has been hypothesized, where mycobacteriophages can be genetically altered
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to contain and express a Rpf. Genetically altered mycobacteriophages can be
subsequently used to target dormant M. tuberculosis and express Rpf endogenously,
thus making M. tuberculosis more susceptible to traditional antibiotic therapy (Gan et
al., 2015).

Last, targeting cell division proteins that are essential for regulating bacterial
dormancy could be an effective strategy. Recently, ZapE, was identified to be a
regulator of UPEC quiescence and the ability of ZapE to hydrolyze nucleotide was
imperative. Since optimal ATPase activity of ZapE is required, targeting and
inactivating ZapE enzymatic function, by uptake of an inhibitor, could serve as an
effective therapeutic strategy in treating dormant UPEC. Inhibition of ZapE would
result in actively growing cells and standard antibiotic treatment could then be used.
There are many cell division linked enzymatic inhibitors that would justify this
approach, for example, peptide inhibitors of FtsA (i.e. FtsAp3) (Paradis-Bleau et al.,
2005) and totarol, a diterpenoid phenol, that has been shown to inhibit FtsZ
polymerization (Jaiswal et al., 2007). These unique strategies for targeting dormant
bacteria may lead toward more effective therapeutics, shorten treatment duration, and
as a result could even reduce the frequency of antibiotic resistant bacteria.

Concluding remarks

Bacterial dormancy is a strategic defense a cell undergoes to survive times of
hardship. There are two transitions concerning dormancy, the entry into and the exit
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from a non-replicating state. Over many years, the entry into and exit from dormancy
has been well characterized in the model organisms of the genus Clostridium, Bacillus,
and Mycobacterium, but information and knowledge were lacking in the genus
Escherichia. All genera previously listed possess species that are known to be human
pathogens and their ability to enter into a dormant state ultimately creates a huge hurdle
in treating bacterial disease and infections in humans.

Considerable progress has been made in recent years characterizing the dormant
state in UPEC. Specific requirements for the establishment and/or maintenance of
quiescence have been identified, for example, a functional TCA cycle. In addition, the
first non-metabolism linked gene was identified by the Camberg lab, a cell division
regulator, ZapE, and may provide future regulatory insight into the formation of
quiescent UPEC. Further, there has been progress in the identification of cues that can
serve as signals to stimulate resuscitation of quiescent cells to re-enter the growth cycle.
The identification of amino acids, sugars, and peptidoglycan fragments serving as cues
during UPEC quiescence is not surprising, since they share similarities to cues identified
as stimulating germination and resuscitation in other spore forming and quiescent
bacteria. However, more work needs to be done as mechanistic insight in both the entry
into and exit from UPEC dormancy is still lacking.
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Fig. 1: Bacillus subtilis entry into and exit from a dormant state
Requirements for the entry into and exit from Bacillus subtilis dormancy described in
this review. Sporulation leads towards the formation of a dormant endospore. Multiple
inputs regulate the entry into dormancy including sensory kinases responding to
(limiting O2, decrease in membrane potential and potassium leakage, increase in
extracellular matrix and biofilm conditions), decrease in amino acid or carbon source
availability and input of specific pentapeptides. Detection of unfavorable conditions
through the sporulation phosphorelay system ultimately results in the phosphorylation
of Spo0A, serving as the master transcriptional regulator of sporulation. Once
manifested, endospores can be stimulated to re-enter the growth cycle by specific
germinants or cues including sugars (i.e., glucose and fructose), amino acids and
peptidoglycan muropeptides.
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Fig. 2: Bacillus subtilis sporulation pathway
Sporulation begins with the elongation of the mother cell and subsequent replication,
elongation and segregation of the nucleoid. Asymmetric cell division follows with the
formation of two sub-polar FtsZ-rings. One Z-ring is eventually disassembled and
prevented from constriction through multiple enzymes (i.e., SpoIID, SPOIIM, SPOIIP,
and MciZ). Further regulatory proteins and sigma factors (i.e., SpoIIE, SpoIIR and
Sigma F, E) are involved with further development of the forespore and activating the
mother cell to utilize its resources to generate a mature. Ultimate lysis of the cell releases
the endospore into the environment.
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Fig. 3: Mycobacterium tuberculosis entry into and exit from a dormant state
Requirements and methods for the entry into and exit from Mycobacterium tuberculosis
dormancy described in this review. Under stressful conditions Mycobacterium
tuberculosis enters into a non-replicating, quiescent state. Quiescent cells can
resuscitate and re-enter the growth cycle through stimulation by specific cues and Rpf.
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Fig. 4: Uropathogenic Escherichia coli entry into and exit from a dormant state
Requirements and methods for the entry into and exit from Uropathogenic Escherichia
coli dormancy described in this review. Uropathogenic Escherichia coli can enter a
quiescent, non-proliferative, state at low density, regulated through metabolism and cell
division. Quiescent cells can then resuscitate through stimulation by specific cues and
re-enter the growth cycle.
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Fig. 5: Escherichia coli cell division pathway
Elongation of the mother cell and subsequent DNA replication and segregation leads
towards the formation of two identical daughter cells. Many cell division proteins act in
a well coordinated manner to influence FtsZ-ring assembly and dynamics that ultimately
lead towards septum formation and constriction. Timely recruitment (i.e., predivisional,
early septal, and late septal) of enzymes to the divisome is crucial for effective cell
division. There are many classes of FtsZ interacting proteins that: recruit (FtsA and
ZipA), cross-link (Zaps (A-D) and potentially ZapE) and antagonize (MinC, SlmA,
SulA, and OpgH) FtsZ cellular dynamics. Further stimulation of late-stage cell division
proteins (i.e., FtsN, Q, B, L, W, I, and AmiC) leads towards peptidoglycan remodeling
and ultimate insertion to form a proper septum that leads towards cell division.
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ABSTRACT
Uropathogenic Escherichia coli (UPEC) are the leading cause of human urinary
tract infections (UTIs) and many patients experience recurrent infection after successful
antibiotic treatment. The source of recurrent infections may be persistent bacterial
reservoirs in vivo that are in a quiescent state and thus are not susceptible to antibiotics.
Here, we show that multiple UPEC strains require a quorum to proliferate in vitro with
glucose as the carbon source. At low cell density, the bacteria remain viable but enter a
quiescent, non-proliferative state. Of the clinical UPEC isolates tested to date, 35%
(51/145) enter this quiescent state, including isolates from the recently emerged,
multidrug-resistant pandemic lineage ST131 (i.e., strain JJ1886) and isolates from the
classic endemic lineage ST73 (i.e., strain CFT073). Moreover, quorum-dependent
UPEC quiescence is prevented and reversed by small molecule proliferants that
stimulate colony formation. These proliferation cues include D-amino acid-containing
peptidoglycan (PG) tetra- and pentapeptides, as well as high local concentrations of Llysine and L-methionine. Peptidoglycan fragments originate from the peptidoglycan
layer that supports the bacterial cell wall but are released as bacteria grow. These
fragments are detected by a variety of organisms, including human cells, other diverse
bacteria and, as we show here for the first time, UPEC. Together, these results show that
for UPEC, (i) sensing of PG stem peptide and uptake of L-lysine modulate the quorumregulated decision to proliferate, and (ii) quiescence can be prevented by both intra- and
interspecies PG peptide signaling.
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IMPORTANCE
Uropathogenic Escherichia coli (UPEC) is the leading cause of urinary tract
infections (UTIs). During pathogenesis UPEC adhere to and infiltrate bladder epithelial
cells where they may form intracellular bacterial communities (IBCs) or enter into a
non-growing or slowly growing quiescent state. Here, we show in vitro that UPEC
strains at low population density enter a reversible, quiescent state by halting division.
Quiescent cells resume proliferation in response to sensing a quorum and detecting
external signals, or cues, including peptidoglycan tetra- and pentapeptides.

KEYWORDS:
quiescence; dormancy; uropathogenic Escherichia coli; proliferant; cue; signal;
quorum; peptidoglycan; pentapeptide; tetrapeptide
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INTRODUCTION
At least 80% of urinary tract infections (UTIs) are caused by uropathogenic
Escherichia coli (UPEC) strains, and 27% of patients with a UTI experience recurrence
within 12 months after successful antibiotic treatment (1-3). UPEC appear to enter a
quiescent, non-growing state within urothelial transitional cells in the bladder wall that
may enable E. coli, long after antibiotic treatment has been terminated, to resume
division within bladder urine after apoptotic release from those cells (4, 5). In this study,
we show that various UPEC strains communicate by releasing and detecting external
signals, or cues (6), which act as proliferants to regulate each bacterium’s decision to
proliferate.

We recently reported the discovery of a quiescent state of E. coli that is common
among UPEC strains (7). E. coli CFT073, a member of the major UPEC lineage
sequence-type (ST) 73, and approximately 80% of ST73 strains tested, proliferate on
glucose minimal agar plates seeded with 106 or more CFU, but become quiescent on
glucose minimal agar when plated at a cell density of less than 106 CFU (7). Moreover,
23% of randomly selected UPEC strains of diverse STs isolated from communityacquired UTIs also become quiescent on glucose minimal plates seeded with less than
106 CFU (7). Remarkably, these results indicate that growth, as measured by colony
formation, of many UPEC strains on glucose minimal agar is quorum-dependent (7).
Alternative sole carbon sources, including acetate, arabinose, and N-acetylglucosamine
(NAG), also lead to cells entering quiescence at low plating density, whereas glycerol,
ribose, and xylose support proliferation (7). We also reported that mini-Tn5 transposon
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insertions in five central carbon metabolism genes (gdhA, gnd, pykF, sdhA, zwf) prevent
quiescence, suggesting that metabolic function must remain intact during quiescence
even though the cells are non-proliferative. CFT073 quiescence is also prevented when
cells are placed near a single colony of actively growing CFT073 or E. coli MG1655, a
K-12 laboratory strain, suggesting that the actively growing cells release one or more
molecules that act as a proliferant (7). Indeed, we showed that L-lysine is a proliferant
for quiescent CFT073 cells, but only in combination with either L-methionine or Ltyrosine, yet CFT073 is not auxotrophic for lysine, methionine or tyrosine, and the
remaining 17 amino acids play no role in preventing CFT073 quiescence (7). Quorumdependent proliferation suggests the ability to sense one or more cell-to-cell
proliferants. In this case of CFT073, the proliferants include L-lysine and L-methionine,
and detection of the proliferant underlies the decision by each individual cell to either
grow and divide or to enter the quiescent state. This suggests that the transition between
the proliferative and quiescent states is controlled by a quorum sensing system (6, 8).

Here we report that quiescent CFT073 cells are filamentous and that L-lysine
import into quiescent CFT073 stimulates proliferation, suggesting that L-lysine
synthesis is inhibited during quiescence. In two pathogenic UPEC strains, including
CFT073, a prototypic ST73 UPEC strain, and JJ1886, a pandemic ST131 strain that
displays increased sensitivity to proliferants, we show that peptidoglycan (PG) stem
peptides prevent quiescence. PG is a component of the bacterial cell wall that contains
polymers of alternating linked sugars NAG and N-acetyl muramic acid (NAM), with
attached stem peptides containing D-amino acids that crosslink. PG fragments have
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been reported to regulate development of Bacillus subtilis and Mycobacterium
tuberculosis (9-11). PG fragments are also normally secreted by growing E. coli (12),
and here we show for the first time that they act as quorum-proliferant molecules in
UPEC. In this study we demonstrate that population-sensing and metabolite availability
modulate the quiescent state of UPEC, and we define an in vitro model system for UPEC
quiescence for further study of UPEC physiology.

RESULTS
Colony formation of UPEC on glucose minimal agar plates is quorum-dependent
and quiescence is reversed by secreted proliferants. UPEC strain CFT073 enters a
quiescent state when plated at low cell density (<106 cells per plate) on glucose minimal
agar yet grows robustly when plated at high cell density (>106 cells per plate),
demonstrating that growth, as measured by colony formation, of CFT073 on glucose
minimal agar plates is quorum-dependent (Fig. 1A). As reported previously, quiescent
CFT073 cells can be resuscitated by challenge with specific external stimuli, called
proliferants, including 5 µl of a solution containing L-lysine (1 mM) and L-methionine
(1 mM), 5 µl of human urine, or a single colony of actively growing E. coli (of strains
CFT073 or MG1655), added to the plate (7). In a soft agar overlay containing 104
quiescent CFT073 cells, we tested the known proliferants and in each case observed the
development of a zone of actively growing colonies surrounding the site of challenge
(Fig. 1B). Without challenge, cells failed to grow throughout the course of the
experiment (24 h) and remained quiescent. We also tested additional clinical isolates
and found that quorum-dependent growth, as measured by colony formation, on glucose
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minimal agar is common among the ST131 UPEC strains in this study (8/33) (Table 1);
however, we discovered that the number of cells constituting a quorum varies among
strains. For example, the ST131 strain JJ1886 was proliferative on glucose minimal agar
at a plating density greater than 103 CFU, but quiescent at or below 103 CFU (Table 1).
Of the 35 strains tested in this study, 10 were reversibly quiescent on glucose minimal
agar, and three of those strains were quiescent at or below a plating density of 103 CFU,
but non-quiescent at 105 CFU (Table 1). These results show that sensitivity for quorum
detection varies by strain, i.e., is strain-specific.

Next, we monitored the zone of colony formation of CFT073 cells as they exited
quiescence over 72 h. First, we poured soft agar plates containing quiescent CFT073
cells seeded at 104 CFU per plate, placed an actively growing colony of CFT073 onto
the surface of each plate by toothpick and measured the zones of colony formation
around the sites of inoculation at 24, 48, and 72 h. We observed that the zone of colony
formation expands in diameter until the entire plate is covered by a lawn of actively
growing cells (Fig. 1C, 1D, and 1E). Two potential scenarios could explain this result.
First, the proliferant(s) that stimulates colony formation of quiescent cells is
continuously released from the toothpicked colony throughout the experiment and
induces colony formation of distal quiescent cells as it diffuses across the plate.
Alternatively, the proliferant(s) that stimulates colony formation from quiescent cells is
released from the toothpicked colony but, upon release of the proliferant, neighboring
and formerly quiescent cells begin secreting their own proliferant, thereby stimulating
adjacent quiescent cells to grow. To distinguish between these possibilities, glucose
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minimal agar plates were seeded with 104 CFT073 cells from a stationary phase liquid
glucose minimal medium culture, and a single CFT073 colony was toothpicked onto the
center of each plate. The plates were then incubated for 24 h. During that time, a small
zone of colony formation formed on each plate around the central toothpicked colony
(Fig. 1C, 1D, and 1E). After the zone had formed at 24 h, the toothpicked colony was
removed to stop the colony from secreting additional proliferant(s). Even after removal
of the toothpicked colony from the plate, the zone of colony formation continued to
expand, unabated, for an additional 48 h and at a similar rate as the control plate, where
the colony had been left intact (Fig. 1D and 1E). These results suggest that the
proliferant(s) propagates across the plate from CFT073 cells as they exit quiescence.
These results further show that quiescent CFT073 cells at the edge of the plate remain
viable and can be stimulated to proliferate for up to 72 h.

Quiescent CFT073 cells are filamentous on glucose minimal agar plates. During
infection, UPEC cells from quiescent intracellular reservoirs (QIRs) display several
different morphologies, including rods, spheres, and filaments (13-15). To determine if
quiescent cells in our in vitro quiescence system also display morphological features
that are distinct from actively growing cells, we compared the cell morphologies of
CFT073 cells under several culture conditions, including LB agar, and glucose minimal
agar supplemented with L-lysine (1 mM) and L-methionine (1 mM) (Fig. 2A). After 24
h on LB agar or on glucose minimal agar supplemented with L-lysine and L-methionine,
colonies were apparent and individual cells collected and analyzed by microscopy
appeared as short rods with mean lengths of 1.72 ± 0.59 μm (n = 200) and 2.33 ± 0.80
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μm (n = 200), respectively (Fig. 2A and 2B), and no cells longer than 6.5 μm were
detected. By contrast, after 24 h on non-supplemented glucose minimal agar plates, no
colonies were detected and quiescent cells harvested from the plate had a broad length
distribution, with a mean length of 7.17 ± 4.34 μm (n = 200), which is 300% longer than
the mean length of cells grown on glucose minimal agar supplemented with lysine and
methionine (Fig. 2A and 2B). Forty-five percent of quiescent cells were longer than 6.5
μm, with 47.5 μm as the upper limit of the range, indicating a filamentous phenotype,
and 16.5% of the filaments appeared to contain one or more incomplete septa (Fig. 2A
and 2B) (Fig. S1A). To assess cells for length changes after extended incubation, we
also measured cell length at 0 h and 48 h after entry into quiescence. At 0 h, cells
harvested from a stationary phase culture grown in liquid glucose minimal medium were
short rods with a mean length of 2.14 ± 0.58 μm (n = 200). After 48 h on glucose
minimal agar plates, quiescent cells were filamentous, with a mean length of 6.84 ± 3.76
μm (n = 72), which is similar to the mean length at 24 h (Fig. S1A and S1B). These
results suggest that quiescent CFT073 cells elongate during the first 24 h on the plate
but fail to complete division.

Lysine import is necessary for lysine to prevent quiescence, but an additional
proliferant is released from actively growing cells. L-lysine is a proliferant for
quiescent CFT073 cells on glucose minimal agar in the presence of L-methionine (7).
To determine whether L-lysine must be imported into CFT073 cells to prevent
quiescence, we constructed a CFT073 lysP insertion-deletion mutant by λ-Red
recombination (Table 2). Of the three known lysine importers in E. coli, LysP is the
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major importer and a member of the amino acid, polyamine, and organocation (APC)
family of transporters (16, 17). CFT073 DlysP cells grew well overnight in liquid
glucose minimal medium, similar to the wild type CFT073 strain (Fig. S2A) and
exhibited quiescence on glucose minimal agar at low cell density (104 cells per plate)
(Fig. 3); yet, it grew robustly when plated at high density (108 cells per plate). Unlike
wildtype CFT073, when 5 µl of a solution of L-lysine (1 mM) and L-methionine (1 mM)
was added to quiescent CFT073 DlysP cells plated at 104 CFU, no colony growth was
observed after 24 h of incubation, suggesting that LysP-dependent transport is critical
for lysine to stimulate proliferation. This also suggests that lysine biosynthesis is
reduced in quiescent cells. CFT073 DlysP was complemented with a plasmid containing
lysP (pLysP), which restored the ability of the strain to proliferate upon addition of Llysine in the presence of L-methionine at low cell density (Fig. 3). Although quiescent
CFT073 DlysP cells failed to respond to L-lysine, they proliferated after a colony of
actively growing CFT073 cells was added to the plate (Fig. 3). Collectively, these results
suggest that import of L-lysine is required for L-lysine to stimulate proliferation and
override the absence of the quorum, and that one or more L-lysine-independent
proliferants that reverse quiescence are secreted from bacterial colonies.

ArgP is a transcriptional regulator of lysP (16, 18). In the absence of lysine,
ArgP positively regulates transcription of lysP, along with several E. coli genes involved
in lysine and PG biosynthesis, including dapB (dihydropicolinate reductase), dapD
(tetrahydrodipicolinate succinylase), lysA (diaminopimelate decarboxylase), and lysC
(aspartokinase III) (16, 18-20). To test whether ArgP plays a regulatory role in quorum-
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dependent colony formation or quiescence, we deleted argP. Like wild type CFT073,
CFT073 ΔargP cells grew well overnight in liquid glucose minimal medium (Fig. S2A)
and were quiescent at low cell density (104 CFU per plate) on glucose minimal agar
(Fig. 3), indicating that ArgP is not essential for inducing quiescence at low density
(Fig. 3). Similar to the result with CFT073 DlysP cells, quiescent CFT073 ΔargP cells
failed to respond to the addition of L-lysine with L-methionine after 24 h of incubation,
but the cells proliferated in response to a colony of CFT073 toothpicked to the center of
a glucose minimal agar plate seeded with 104 CFU of CFT073 ΔargP (Fig. 3).
Complementation of CFT073 DargP with the wildtype CFT073 argP gene on a plasmid
(pArgP) restored the ability of the strain to respond to L-lysine in the presence of Lmethionine at low cell density (Fig. 3). Since LysP expression has been reported to be
repressed 35-fold in E. coli argP mutants (20), this result both (i) supports the
conclusion that external L-lysine must be transported into CFT073 via LysP in order to
prevent quiescence and (ii) confirms that expression of LysP is regulated by ArgP.
Together, these results also suggest that there is a molecule(s) other than L-lysine
secreted by actively growing cells that stimulates proliferation of quiescent CFT073
cells. We previously reported that cell-free culture supernatants prepared from CFT073
grown in liquid glucose minimal medium contain L-lysine (7). Therefore, to confirm
that it is not L-lysine secretion from the actively growing cells in the colony that
reactivates quiescent cells and induces proliferation, we constructed a lysine
biosynthetic mutant of CFT073 by deletion of lysA (Table 2). This strain grows in
glucose minimal medium supplemented with L-lysine but fails to proliferate on glucose
minimal agar without lysine in response to an actively growing colony of CFT073 cells,
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which are capable of synthesizing, and therefore likely releasing, L-lysine (Fig. S3A).
This is consistent with the suggestion that the molecule(s) secreted by cells that
stimulates proliferation is not L-lysine.

To further clarify why the population threshold that defines a quorum varies
between strains, we investigated the ST131 clinical isolate JJ1886, which exhibits
quiescence on glucose minimal agar at or below a plating density of 103 CFU, but grows
robustly on such plates at 105 CFU and in liquid glucose minimal medium (Fig. 4A and
S2B). We observed that 5 µl of a solution of L-lysine (1 mM) alone is sufficient to
promote colony formation and prevent quiescence of JJ1886 plated at low density on
glucose minimal agar (103 CFU per plate), although colony formation is more efficient
in the presence of L-methionine (1 mM), and L-methionine (1 mM) alone does not
stimulate colony formation (Fig. 4B). Since quiescent JJ1886 cells on glucose minimal
agar proliferate in the presence of L-lysine alone, we titrated the L-lysine concentration
to determine the threshold for stimulation of colony formation and compared JJ1886 to
CFT073. We determined that a low concentration of L-lysine (5 µl of 0.1 mM) is
sufficient to promote proliferation of quiescent JJ1886 cells (103 CFU/plate), whereas
quiescent CFT073 cells (103 CFU/plate) proliferated at a higher concentration of Llysine (>0.5 mM) and only in the presence of L-methionine. These results suggest that
although JJ1886 behaves phenotypically similar to CFT073 with respect to quiescence,
it is more sensitive to detecting or responding to an external proliferant(s) that prevents
quiescence. We then tested if quiescent JJ1886 also responds to the other known
CFT073 proliferants, including 5 µl of urine or a colony of actively growing E. coli
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cells, and observed that both agents were effective for stimulating proliferation of
quiescent JJ1886 cells (Fig. 4B).

Since L-lysine stimulates proliferation of both JJ1886 and CFT073, we tested 5
µl of D-lysine (1 mM) and 5 µl of the biosynthetic lysine precursor mesodiaminopimelic acid (Dap) (1 mM) for stimulating proliferation of quiescent cells. Both
agents failed to stimulate colony formation from quiescent CFT073 and JJ1886 (Fig.
S3B and S3C).

Peptidoglycan fragments prevent UPEC quiescence. Next, we considered PG as a
potential cue or signal that would communicate a quorum since PG fragments, including
di-, tri-, and tetrapeptides, are normally secreted by actively growing bacterial cells
including E. coli (10, 12, 21, 22). We tested if peptidoglycan fragments from E. coli
could prevent quiescence and stimulate proliferation of CFT073 and JJ1886.
Peptidoglycan was digested with mutanolysin, a mixture of two N-acetylmuramidases
and an N-acetylmuramyl-L-alanine amidase, to release a heterogeneous mixture of
peptidoglycan fragments, including various muropeptides and stem peptides (Fig. 5A).
Addition of the total mixture of digested peptidoglycan fragments from E. coli induced
proliferation of quiescent JJ1886 cells, plated at 103 CFU per plate (Fig. 5A), and
quiescent CFT073 cells, plated at 104 CFU per plate (Fig. S4A). Titrating the amount
of total peptidoglycan added to the agar plate revealed a dose-dependent response,
leading to differences in the zones of colony formation around the site of addition (Fig.
S4B). Digested peptidoglycan from B. subtilis and Staphylococcus aureus also
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stimulated proliferation of quiescent JJ1886 and CFT073 cells (Fig. S4C and S4D).
Furthermore, peptidoglycan fragments were also effective for stimulating proliferation
of quiescent CFT073 DlysP cells, indicating that the peptidoglycan response is
independent of lysine import (Fig. S5A). Interestingly, these results show that quiescent
E. coli cells respond to PG fragments from various bacterial species, which can differ
in the identity of the amino acid at the third position of the stem peptide, usually mesoDap (i.e., E. coli) or L-lysine (i.e., S. aureus) (10, 23, 24).

Peptidoglycan stem peptides act as proliferants for quiescent JJ1886 and CFT073
cells. To identify which fragment(s) of digested PG stimulates proliferation of quiescent
cells, we performed high performance liquid chromatography-mass spectrometry
(HPLC-MS) on E. coli PG fragment mixtures (Fig. 5A) and tested fractions across the
elution for the ability to promote proliferation of quiescent JJ1886 cells. We found that
early fractions that were collected with retention times up to 10 min were sufficient to
stimulate proliferation of quiescent JJ1886 cells (Fig. S5B). Tandem mass spectrometry
confirmed that these fractions contain low molecular weight peptidoglycan fragments,
consistent with stem peptides, such as the tri- and tetrapeptides (Table S1). In contrast,
later eluting fractions containing muropeptides did not stimulate proliferation of
quiescent JJ1886 cells (Fig. S5B).

To further explore the molecular determinants of PG peptides that stimulate
proliferation of quiescent cells, we compared several high-purity PG peptide fragments
of varying amino acid compositions and lengths (Table S1). We observed that a
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tripeptide, which could be generated from known amidase and carboxypeptidase
activities in the E. coli periplasm (L-Ala-D-Glu-mDap), failed to stimulate proliferation
of quiescent JJ1886 cells (Fig. 5B). However, a peptidoglycan pentapeptide, L-Ala-DGlu-L-Lys-D-Ala-D-Ala (A-E-K-A-A), which is similar to the stem pentapeptide used
for S. aureus peptidoglycan synthesis, stimulated proliferation of quiescent JJ1886 (Fig.
5C) and CFT073 (Fig. S5A) cells. We also tested a smaller fragment of the pentapeptide,
acetyl-L-Lys-D-Ala-D-Ala (K-A-A) but did not observe stimulatory activity (Fig. S6A).
Fragments including the disaccharide moiety alone, containing NAG and NAM (NAGNAM) (Fig. 5D), and higher molecular weight molecules with the attached stem peptide
(i.e., disaccharide tetrapeptide) (Fig. 5E), in various states of crosslinking, eluted later,
after 10 min (Fig. S7), and had no proliferant activity. NAG-NAG, NAG, and NAM
were also tested, but none of these sugars stimulated proliferation of quiescent cells
(Fig. S6B).

To determine if a peptidoglycan stem peptide longer than three amino acids
and derived from E. coli stimulates proliferation of quiescent cells, we generated
tetrapeptide in situ by digesting purified disaccharide tetrapeptide (isolated by HPLC)
with AmiD, an amidase from E. coli (22). AmiD cleaves a stem peptide from attached
sugars (Fig. S8A). After cleavage to release the tetrapeptide, the reaction products
were highly active for stimulating proliferation of both quiescent JJ1886 cells (Fig.
5F) (Fig. S8B) and quiescent CFT073 cells (Fig. S8C). Since NAG-NAM displays no
activity alone, these results suggest that peptidoglycan peptides from E. coli
(tetrapeptide) and S. aureus (pentapeptide) likely function as proliferants.
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Finally, to further clarify if PG peptides exert their function without entering
the cytoplasm or if they are imported into a quiescent cell and then enter the
peptidoglycan recycling pathway (22), we constructed JJ1886 strains deleted for the
oligopeptide transporter operon, oppABCDF (25-29), and also the peptidoglycan
tripeptide-specific delivery protein mppA (27, 30-32). Both deletion strains grew well
in liquid glucose minimal medium and became quiescent when plated at 103 CFU per
plate, similar to parent strain JJ1886; furthermore, like JJ886, both strains were
stimulated to proliferate by addition of stem peptides to the plate (Fig. S8B and S8D),
indicating that it is not necessary for the stem peptides to enter the cytoplasm via the
Opp transporter in order to act as a proliferant to overcome quiescence.

DISCUSSION
Here, we show that two virulent UPEC strains, CFT073 and JJ1886, enter a
quiescent state on glucose minimal agar, where glucose is not limiting, and this state is
prevented and reversed by proliferants. These proliferants, which prevent quiescence
and promote colony formation, include peptidoglycan stem peptides consisting of four
(e.g., E. coli) or five (e.g., S. aureus) amino acids, L-lysine and L-methionine, and
human urine, which contains a high concentration of free amino acids (7). Quiescence
is a slow- or non-growing physiological state described for E. coli that is common
among UPEC strains (i.e., 51/145 isolates tested) and is quorum-regulated. The
quiescent state is adopted by an entire population of cells under a given growth
condition, in contrast to a persister state, which occurs in a small percentage of cells
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within a population (33-37). Adoption of a quiescent, non-proliferative state would
require many physiological systems to slow (e.g., transcription, translation) or stop (e.g.,
DNA replication, division, and peptidoglycan synthesis). Accordingly, we observed that
quiescent cells adopt a filamentous morphology, failing to successfully divide or
proliferate despite extended incubation (Fig. S1A). Finally, different strains respond to
known proliferants with varying sensitivities, suggesting that either the sensitivity of
detection or the regulatory control over physiological pathways varies among strains.
For example, L-lysine is sufficient to induce proliferation of quiescent JJ1886 cells (Fig.
4B), whereas L-lysine must be supplemented with either L-methionine or L-tyrosine to
induce proliferation of quiescent CFT073 cells (7). While lysine import is one way to
overcome quiescence, stimulation by peptidoglycan stem peptides occurs independently
of the lysine importer lysP, suggesting that there are multiple regulatory inputs that
enable reinitiation of the cell cycle. It is also possible that detection of peptidoglycan
fragments stimulates lysine biosynthesis or increases intracellular lysine concentration
in a coordinated manner, which then induces proliferation.

Muropeptide fragments are known to resuscitate dormant Mycobacterium
smegmatis (38) and to stimulate B. subtilis endospores to germinate (11). Here we
showed that in E. coli, PG stem tetra- and pentapeptide fragments not only cause cells
to reenter the cell cycle but may also act as a signal or cue to communicate the presence
of a quorum, independent from uptake by the Opp import system. Previously, it was
shown that an oppA mutant is far less infective in a mouse UTI model than the wildtype
(39), and it was suggested that small oligopeptides, present in high concentration in
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urine (39), are imported and serve as major nutrients for CFT073 growth in urine (39).
Here, neither the pentapeptide nor the tetrapeptide tested entered the quiescent cells via
Opp, suggesting that they are imported by a second, presently unknown, oligopeptide
permease, or act as signals in the periplasm and are recognized by a membrane receptor
or signal transduction system that, when activated, promotes cell proliferation. The
serine/threonine kinase PknB is a widely conserved PG binding protein that is important
for germination of spores in B. subtilis (11); however, no similar proteins have been
found thus far in E. coli.

The cause(s) of recurrent UTIs are complex (40); however, it appears that UPEC
can bind to, enter, and replicate within superficial facet cells in the mouse and human
bladder epithelium, resulting in intracellular biofilm-like communities (IBCs) (40, 41).
IBCs escape from infected superficial facet cells within hours of development and
several cycles of IBC formation occur, but each successive round is associated with a
reduced replication rate and smaller IBCs (15). The infected superficial facet cells
exfoliate, exposing underlying transitional epithelial cells that become infected with
IBC-derived UPEC progeny. Upon infection of transitional cells, small numbers of
UPEC appear to enter a latent or quiescent intracellular state in endosomal vesicles (2
to 12 cells/vesicle), establishing QIRs (42) that are resistant to antibiotic treatment and
are a possible cause of recurrent UPEC infection. If the physiology of UPEC quiescence
in vitro is similar to that in vivo, understanding how PG stem peptides prevent in vitro
quiescence at the molecular level may help inform how to prevent recurrent UPEC
infections in humans.
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MATERIALS AND METHODS

Bacterial strains and growth conditions. E. coli strains and plasmids used in this
study are listed in Table 2. Plasmids for complementation of both CFT073 DlysP and
CFT073 DargP gene deletions were constructed using expression vector pBAD24.
Both genes were amplified from CFT073 by whole colony PCR (lysP, 5’
atcaagaattcacatgggttccgaaactaaaactacagaag 3’, 5’
tagataagcttttatttcttatcgttctgcgggaacttc 3’; argP, 5’
atcaagaattcacatgcaacccgacacaaaattgtgtcatag 3’, 5’
tagataagcttttaatcctgacgaagaactttgtgaccataatcg 3’). The resulting PCR products were
digested with EcoRI and HindIII. Digested PCR products were ligated into
EcoRI/HindIII-digested pBad24. Both pLysP and pArgP plasmid constructs were
verified by sequencing and then transformed into either CFT073 DlysP or CFT073
DargP deletion strains by electroporation. To test for complementation, transformants
were grown overnight in 0.4% glucose M9 minimal medium with ampicillin (50 μg
ml-1) and were assayed for quiescence on 0.2% glucose minimal agar supplemented
with arabinose (0.1%), where indicated.

The amiD gene sequence coding for residues 18 through 276 was amplified from
E. coli MG1655, cloned into pET-24b using NdeI/HindIII restriction sites to incorporate
a

C-terminal

hexahistidine

tag

(5’
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actgacatatggcaggcgaaaaaggcat

3’,

5’

gcagtaagcttatcctgcccgtatttc 3’) and expressed in BL21 (λde3). This resulted in removal
of the N-terminal signal sequence and lipid modification site.

Clinical UPEC isolates were obtained from the collections of J. Johnson (29
strains) and E. Sokurenko (5 strains) (Table 1). Lennox broth (LB) supplemented with
agar (LB agar) was used for routine cultivation. Liquid glucose (0.2% or 0.4%, where
indicated) M9 minimal medium and 0.2% glucose M9 minimal agar plates were
prepared as described previously (7). Gene deletions were constructed by λ-Red
recombination as described in Datsenko and Wanner and confirmed by sequencing (43).
Culture density was monitored by growing cells in liquid 0.2% glucose M9 minimal
medium and measuring OD600 at the indicated times.

Quiescence assay. Quiescence assays were performed as described previously (7).
Briefly, CFT073 and JJ1886 wild type and mutant strains were grown on LB agar plates
overnight at 37 °C. An isolated colony was used to inoculate 5 ml of 0.4% glucose M9
minimal medium, incubated at 37 °C with shaking overnight, and then diluted to
between 103 to 108 CFU, as indicated, in 3 ml 0.2% glucose M9 minimal medium
containing 0.75% Difco noble agar held at 45 °C (soft agar). Inoculated soft agar was
immediately poured onto plates containing a 12 ml layer of 0.2% glucose M9 minimal
medium with 1.5% noble agar or directly into an 8.5 cm2 polystyrene culture dish.
Putative proliferants, including actively growing cells, amino acids, Dap (2,6diaminopimelic acid), sterile human urine, and peptidoglycan fragments, were added
and plates were incubated at 37 °C for 24 to 72 h, where indicated, and then imaged.
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Microscopy. Overnight cultures of CFT073 were grown to stationary phase in 0.4%
glucose M9 minimal medium. Five µl of a 3-log diluted culture was spotted onto LB
agar or 0.2% glucose M9 minimal medium with 1.5% noble agar and, where indicated,
supplemented with L-lysine (1 mM) and L-methionine (1 mM), then allowed to dry for
1 h at room temperature. Plates were incubated at 37 °C for 24 or 48 h. Cells were
harvested onto a glass cover slip, resuspended in phosphate-buffered saline (PBS) with
ethylenediaminetetraacetic acid (EDTA) (1 mM) and applied to an agar gel pad
containing 0.2% glucose M9 minimal medium with 0.5% noble agar. Cells were
visualized by differential interference contrast (DIC) microscopy using a Zeiss LSM
700, and images were captured on an AxioCam HRc high-resolution camera with ZEN
2012 software. Images were processed using Adobe Photoshop CC and analyzed using
NIH ImageJ software.

Peptidoglycan fragment separation and analysis. E. coli CFT073 was inoculated in
one liter of M9 minimal medium containing 0.4% glucose and incubated for 24 h
shaking (175 rpm). Methods used for PG isolation were adapted from Desmarais et al.,
2014 (44). Briefly, cells were harvested at 5,000 x g for 10 min at room temperature and
pellets were resuspended in 3 ml of M9 minimal medium. Cell suspensions were
transferred into 6 ml of 6% sodium dodecyl sulfate (SDS) and boiled for 3 h with
stirring. After 3 h, heat was discontinued, and cell suspensions were stirred overnight at
room temperature. Cell suspensions were centrifuged at 262,000 x g for 30 min, pellets
were resuspended in liquid chromatography mass spectrometry (LCMS) grade water
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and further centrifugation and wash steps occurred until no SDS remained. The final
pellet was resuspended in 900 μl of 10 mM Tris-HCl with 0.06% w/v NaCl and 100 µg
of Pronase E was added to the cell suspension and then incubated for 2 h at 60 °C. After
incubation, 200 μl of 6% SDS was added and the mixture was boiled at 100 °C for 30
min. Samples were centrifuged at 262,000 x g for 30 min and washed 4 times with
LCMS grade water. The final pellet was resuspended in 200 μl of PBS and incubated at
37 °C overnight with 200 U of mutanolysin (M9901, Sigma-Aldrich), which includes a
mixture of three enzymes including N-acetylmuramidase M1 (b-1,4-N,6-Odiacetylmuramidase), N-acetylmuramidase M2 (b-1,4-N-acetylmuramidase), and the
proteolytic enzyme N-acetylmuramyl-L-alanine amidase, which cleaves the lactylamide
bond releasing stem peptide. Samples were centrifuged at 16,000 x g for 10 min to
remove cellular debris, PG supernatant was collected for further testing. Mutanolysin
was removed by ultrafiltration using a sterile polyethersulfone filter with a 3-kDa
molecular weight cut-off. Separation and initial chemical characterization were carried
out by liquid chromatography mass spectrometry (LCMS) on a Thermo Fisher ISQ EC
coupled to a Shimadzu Prominence-i LC-2030 system. Chemical characterization of
pure compounds was undertaken using electrospray ionization mass spectrometry
(ESIMS) using an AB Sciex TripleTOF 4600 spectrometer and LCMS/MS experiments.

Analytical high-performance liquid chromatography (HPLC) was used to purify
the PG extract. HPLC experiments were performed on a Shimadzu prominence-I LC2030C equipped with a PDA detector model LC-2030/2040, pump LC-2030, and
autosampler LC-2030. Preparative HPLC experiments were completed with a Waters
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XBridge Analytical C18 5 μm, 4.6 × 250 mm column at 30 °C using a solvent gradient
of 10-100% B (5 mM ammonium acetate with 15% acetonitrile pH 4.89) run over 16
min against solvent A (5 mM ammonium acetate pH 4.37). Solvent B was held at 10%
for 4 min prior to the gradient and 100% B was held for a subsequent 4 min at the
conclusion of the method. Individual peaks were collected according to 205 nm
absorbance values at 205 nm. Methods of LCMS/MS were performed on a AB Sciex
TripleTOF 5600 spectrometer coupled to a Waters H class UPLC. Methods of LC
mirrored that of initial screening with an adjusted flow rate of 0.5 ml min-1 on an
XBridge Analytical C18 5 μm, 4.6 × 250 mm column. Acquisition (SWATH) was
performed in positive ionization mode. The method specific parameters were as follows:
gas 1 (GS1) 55 psi, gas 2 (GS2) 60 psi, curtain gas (CUR) 25 psi. The source-specific
parameters were: temperature (TEM) 500 °C, ion spray voltage floating (ISVF) 5500
V, declustering potential (DP): 100, collision energy (CE) 10 and collision energy
spread (CES) 15. An initial time-of-flight (TOF) scan was collected from m/z 100 to
1500 and SWATH data was acquired (m/z 200-1100) over 36 SWATH windows per
cycles with a window size of m/z 25 and a m/z 1 overlap between windows.

Peptidoglycan from B. subtilis (69554, Sigma-Aldrich) or S. aureus (77140,
Sigma-Aldrich) (10 mg ml-1) was incubated with 200 U of mutanolysin at 37 °C
overnight. Peptidoglycan stem peptide fragments including ‘A-E-K-A-A’ pentapeptide
(L-Ala-D-Glu-L-Lys-D-Ala-D-Ala (A0910, Sigma-Aldrich), ‘K-A-A’ tripeptide
(acetyl-L-Lys-D-Ala-D-Ala) (A6950, Sigma-Aldrich), and ‘A-E-Dap’ tripeptide (LAla-D-Glu-mDap) (AS-60774, AnaSpec), and NAG-NAM (A178230, Toronto
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Research Chemicals) were each tested at 5 μl (2 mM) against strains JJ1886, JJ1886
DoppABCDF, and JJ1886 DmppA (103) after growth on M9 minimal agar with 0.2%
glucose for 24 h at 37 °C.

Amidase cleavage of disaccharide tetrapeptide. E. coli BL21 lde3 cells containing
expression vector pET-AmiD, modified to removed 17 amino acids form the Nterminus, were grown in LB supplemented with 50 μg ml-1 kanamycin at 37 °C to an
OD600 of 0.8. Expression was induced with isopropyl-β-D-thiogalactoside (1 mM) for 3
h at 30 °C. Cells were harvested by centrifugation at 6,000 x g for 30 min at 4 °C and
resuspended in 25 ml of 25 mM Tris-HCl (pH 7.8) buffer containing 150 mM NaCl, 1
mM MgCl2, and 10% glycerol. Cells were lysed by French press. Soluble cell extracts
were collected by centrifugation at 30,000 x g for 30 min at 4 °C, then applied to
TALON Superflow resin (GE Healthcare), washed with 10 column volumes of lysis
buffer and eluted with an imidazole gradient. Buffer was exchanged by PD-10 desalting
column to remove imidazole. Isolated E. coli PG disaccharide tetrapeptide was digested
with 315 ng of AmiD in 8.5 mM Tris-HCl (pH 7.8), 50 mM NaCl, 0.3 mM MgCl2, and
3% glycerol for 26 h at 37 °C. Cleavage was confirmed by LCMS analysis as described
above.

SUPPLEMENTAL MATERIAL
Supplemental material is available online for this paper.
TABLE S1
FIG S1, S2, S3, S4, S5, S6, S7, S8
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TABLE 1 Prevalence of quiescence among UPEC ST131 isolates
Strain

CFT073
Nissle 1917
JJ1886
JJ1887
JJ2547
JJ2050
JJ2528
MVAST0036
MVAST014
H17
JJ1901
JJ2087
JJ1999
MVAST167
MVAST020
JJ2134
JJ2183
JJ2489
QUC02
JJ2118
JJ2193
JJ2210
JJ2578
JJ2608
MVAST038
MVAST046
MVAST077
MVAST084
MVAST131
MVAST158
MVAST179
JJ2546
JJ2548
JJ2963
JJ2974

Sequence
type

ST131
Clade

ST73
ST73
ST131
ST131
ST131
ST131
ST131
ST131
ST131
ST131
ST131
ST131
ST131
ST131
ST131
ST131
ST131
ST131
ST131
ST131
ST131
ST131
ST131
ST131
ST131
ST131
ST131
ST131
ST131
ST131
ST131
ST131
ST131
ST131
ST131

n/a
n/a
H30Rx/ C2
H30Rx/ C2
H30Rx/ C2
H30R1/ C1
H30R1/ C1
H30R1/ C1
H22/ B0
H22/ B
H22/ B
H41/ A
H41/ A
H30Rx/ C2
H30Rx/ C2
H30Rx/ C2
H30R1/ C1
H30R1/ C1
H30R1/ C1
H30R1/ C1
H30R1/ C1
H30R1/ C1
H30R1/ C1
H30R1/ C1
H30R1/ C1
H30R1/ C1
H30R1/ C1
H30R1/ C1

Quiescent at 103 CFU
and reversed by
Lys and Met a
+b
+b
+c
+c
+c
+b
+
+b
+b
+b

a

Source,
reference
(7)
(7)
J. Johnson
J. Johnson
J. Johnson
J. Johnson
J. Johnson
J. Johnson
J. Johnson
J. Johnson
J. Johnson
J. Johnson
J. Johnson
J. Johnson
J. Johnson
J. Johnson
J. Johnson
J. Johnson
J. Johnson
J. Johnson
J. Johnson
J. Johnson
J. Johnson
J. Johnson
J. Johnson
J. Johnson
J. Johnson
J. Johnson
J. Johnson
J. Johnson
J. Johnson
E. Sokurenko
E. Sokurenko
E. Sokurenko
E. Sokurenko

Strains were seeded at 103 CFU and 105 CFU on 0.2% glucose M9 minimal agar
plates and incubated at 37 °C for 24 h, (+) represents quiescent, (-) represents nonquiescent.
b
Denotes strains that are quiescent when seeded at both 103 CFU and 105 CFU on
0.2% glucose M9 minimal agar and grown at 37 °C for 24 h.
103

c

Denotes strains that are quiescent when seeded at 103 CFU, but non-quiescent when
seeded at 105 CFU on 0.2% glucose M9 minimal agar plates and grown at 37 °C for 24
h.
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TABLE 2 E. coli strains and plasmids used for genetic analyses and constructions in
this study
E. coli
Strain or Plasmid
Strains
CFT073 Strr

Identifier

Spontaneous streptomycin- CFT073
resistant mutant of CFT073

Source,
reference or
construction
(7)

CFT073

Original clinical isolate

CFT073WT

(45)

MG1655

LAM-rph-1
F- ompT gal dcm lon
hsdSB(rB- mB-) λ(de3[lacI
lacUV5-T7 gene 1 ind1
sam7 nin5])
CFT073 Strr DlysP::parEkan
CFT073 Strr DargP::cat
CFT073 DlysA::cat

MG1655

(46)

BL21 (λde3)
ED0052
ED0070
ED0169
JJ1886
ED0118
ED0131
Plasmids
pKD46
pKD3
pKD267
pKD119
pBAD24
pLysP
pArgP
pet-AmiD
a

Relevant Genotype
Description

JJ1886 DmppA::cat
JJ1886 DoppABCDF::cat
amp
cat
kan
tet
amp (expression vector)
amp Para::lysP
amp Para::argP
kan, (DN17)amiD-His6

BL21 (λde3)

EMD Millipore,
USA

CFT073 DlysP

CFT073; λred

CFT073 DargP
CFT073 DlysA
JJ1886
JJ1886 DmppA
JJ1886
DoppABCDF

CFT073; λred
CFT073WT; λred
(47)
JJ1886; λred

pLysP
pArgP

JJ1886; λred
(43)
(43)
B. Wanner a; (48)
(43)
(49)
This study
This study
This study

J. Teramoto, K. A. Datsenko, and B. L. Wanner, unpublished construction
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FIG 1 The quorum-regulated quiescent state of E. coli CFT073 cells on glucose M9
minimal agar is reversible. (A) CFT073 cells were seeded on 0.2% glucose M9 minimal
agar plates and incubated for 24 h at 37 °C at low density (104 CFU), which promotes
quiescence, and at high density (108 CFU), which prevents quiescence and promotes
proliferation, leading to a lawn of colony growth on the agar plate. (B) CFT073 cells
(104 CFU) were plated onto M9 minimal agar with 0.2% glucose. A 5 μl solution of Llysine (1 mM) and L-methionine (1 mM), sterile human urine, or an actively growing
colony of CFT073 was transferred to the center of the plate, cells were incubated for 24
h at 37 °C, and the zone of growth, as measured by colony formation surrounding the
challenge site, was monitored. (C) The zone of colony formation extended outward for
72 h after addition of the actively growing colony of CFT073 (proliferant) to the center
of the plate containing quiescent cells. (D) The diameter of the zone containing colonies
was measured and plotted with time. Data from three replicates are shown with error as
standard deviation. (E) Zonal expansion assay was repeated as in (C), but the actively
growing colony at the center of the plate (proliferant) was removed at 24 h. The diameter
of the zone containing colonies continued to expand with time after removal of the initial
proliferant, similar to the expansion measured in the presence of proliferant (D). In (B),
(C), and (E), white arrows indicate position of proliferant addition, brackets indicate the
zone of colony growth and scale bars are 1 cm in length. Images shown in (A), (B), (C),
and (E) are representative of at least three independent replicates.
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FIG 2 Quiescent CFT073 cells are filamentous at 24 h. (A) CFT073 cells were grown
on LB agar or 0.2% glucose minimal agar at 37 °C with and without L-lysine (1 mM)
and L-methionine (1 mM), harvested at 24 h and visualized by DIC microscopy. Scale
bars are 5 μm in length. (B) Violin plot representing cell length distribution at 24 h for
200 cells grown under conditions described in (A).
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FIG 3 Quiescent CFT073 DlysP and DargP cells fail to proliferate with L-lysine. All
strains, including CFT073, CFT073 DlysP, CFT073 DargP, were plated on M9 minimal
agar with 0.2% glucose at 104 CFU and then challenged with a 5 μl solution of L-lysine
(1 mM) and L-methionine (1 mM), sterile human urine or an actively growing colony
of MG1655 transferred to the center of the plate. CFT073 DlysP cells containing pLysP
or pBad24, where indicated, were supplemented with 50 μg ml-1 ampicillin and 0.1%
arabinose. CFT073 DargP cells containing pArgP or pBad24, where indicated, were
supplemented with 50 μg ml-1 ampicillin. Plates were incubated at 37 °C for 24 h. Scale
bar is 1 cm in length. Images shown are representative of three independent replicates.
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FIG 4 ST131 strain JJ1886 displays quorum dependent colony formation. (A) JJ1886
cells were plated onto 0.2% glucose M9 minimal agar and LB agar at 105 and 103 CFU.
JJ1886 displays quorum dependent colony formation at 103 CFU on glucose M9
minimal agar. (B) JJ1886 (103 CFU) were plated onto 0.2% glucose M9 minimal agar.
A 5 μl solution of L-lysine (1 mM) and L-methionine (1 mM), L-lysine (1 mM), Lmethionine (1 mM), sterile human urine, or an actively growing colony of CFT073 was
transferred onto a JJ1886-seeded plate and plates were incubated for 24 h at 37 °C. Scale
bars are 1 cm in length. Images shown in (A) and (B) are representative of at least three
independent replicates.
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FIG 5 Peptidoglycan fragments promote proliferation of quiescent JJ1886 cells.
LCMS total ion counts (TIC) including (A) mutanolysin-digested crude E. coli PG,
which was tested for stimulating proliferation of quiescent JJ1886 cells plated at 103
CFU on 0.2% glucose M9 minimal agar, inset; (B) elution of a PG tripeptide (L-AlaD-Glu-mDAP), [M+H]+ 391.275 (m/z), similar to an E. coli fragment and
corresponding test for quiescence reversal, inset; (C) elution of a PG pentapeptide (LAla-D-Glu-L-Lys-D-Ala-D-Ala), [M+H]+ 489.380 (m/z), similar to a S. aureus PG
pentapeptide and corresponding test for quiescence reversal, inset; (D) elution of a
NAG-NAM disaccharide, [M+K]+ 535.128 (m/z), and corresponding test for
quiescence reversal, inset; and (E) elution of a disaccharide tetrapeptide, [M+H]+
940.396 (m/z), isolated from crude E. coli PG and corresponding test for quiescence
reversal, inset; (F) products of the enzymatic reaction of E. coli-derived disaccharide
tetrapeptide isolated from HPLC and then digested with AmiD to produce tetrapeptide
(L-Ala-D-Glu-mDAP-D-Ala), [M+H]+ 462.198 (m/z), and corresponding test of
reaction products for quiescence reversal, inset. Candidate proliferants were collected
and tested in the quiescence assay as described in Materials and Methods and plates
were incubated at 37 °C for up to 24 h. Where shown, white arrows indicate position
of proliferant addition. Scale bars are 1 cm in length. Images of quiescence assay
plates shown in (A-F) are representative of at least three independent replicates.
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FIG S1 Quiescent CFT073 cells are filamentous at 48 h. (A) CFT073 cells were grown
on 0.2% glucose M9 minimal agar plates at 37 °C, harvested at 0, 24, and 48 h and
visualized by DIC microscopy. Scale bars are 5 μm in length. Arrows indicate position
of failed septa. (B) Violin plot representing cell length distribution at 0 h (n = 200) and
48 h (n = 72), grown under conditions described in (B).
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FIG S2 UPEC strain growth in glucose M9 minimal medium. (A) CFT073, CFT073
DlysP, CFT073 DargP, and (B) JJ1886 were grown in liquid 0.2% glucose M9 medium
at 37 °C for 24 h with OD600 measured every 2 h from 0 to 12 h and 22 to 24 h. All
strains grow robustly overnight in glucose M9 minimal medium. Data from three
replicates are shown.
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FIG S3 Lysine and regulation of quiescence in CFT073 and JJ1886. (A) CFT073 (104
CFU) and CFT073 DlysA (104 CFU) were seeded on 0.2% glucose M9 minimal agar,
challenged with an actively growing colony of CFT073 and monitored for reversal of
quiescence for 42 h at 37 °C. (B) CFT073 (104 CFU) and (C) JJ1886 (103 CFU) were
seeded on 0.2% glucose M9 minimal agar and challenged with a solution of either (B)
L-lysine (1 mM) and L-methionine (1 mM), D-lysine (1 mM) and L-methionine (1
mM), or Dap (1 mM) and L-methionine (1 mM), (C) L-lysine (1mM), D-lysine (1 mM),
or Dap (1 mM). Plates were incubated for 24 h at 37 °C and imaged. Arrows indicate
position of stimulant addition. Scale bars are 1 cm in length. Images shown are
representative of at least three independent replicates.
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FIG S4 E. coli, B. subtilis, and S. aureus peptidoglycan fragments stimulate
proliferation of CFT073 and JJ1886 cells. (A, C) CFT073 (104 CFU) and (D) JJ1886
(103 CFU) cells were plated onto 0.2% glucose M9 minimal agar plates and challenged
with a mixture of digested (A) CFT073 PG, (C, D) B. subtilis or S. aureus PG or (A)
PBS. Plates were incubated (D) 24 h at 37 °C and (A, C) 48 h at 37 °C. (B) Digested E.
coli PG was titrated (0 to 10 μg) on JJ1886 seeded plates and CFU per zone was
calculated. White arrows indicate position of stimulant addition. Scale bars are 1 cm in
length. Images shown are representative of at least three independent replicates.
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FIG S5 Peptidoglycan fragments, including a S. aureus pentapeptide, stimulate
proliferation of quiescent UPEC cells. (A) CFT073 (104 CFU), CFT073 DlysP (104
CFU), and (B) JJ1886 (103 CFU) cells were plated onto 0.2% glucose M9 minimal agar
and challenged with a mixture of digested B. subtilis peptidoglycan (50 μg), S. aureus
pentapeptide (A-E-K-A-A) (5 μg) or water. Plates were incubated for 48 to 72 h at 37
°C in (A). (B) Quiescent JJ1886 cells were challenged with early (4 to 10 min) or late
(10 to 20 min) fractions of mutanolysin digested E. coli peptidoglycan fractionated by
HPLC. Plates were incubated for 24 h at 37 °C. Arrows indicate position of proliferant
addition and scale bars are 1 cm in length. Images shown are representative of at least
three independent replicates.
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FIG S6 Candidate proliferants tested for reversal of JJ1886 quiescence. LCMS profiles
of total ion counts (TIC) for a tripeptide (acetyl-L-Lys-D-Ala-D-Ala), 331.25 [M+H]+
(m/z) (A), similar to an S. aureus PG fragment, which was tested for stimulating
proliferation of quiescent JJ1886 cells plated at 103 CFU per plate on 0.2% glucose M9
minimal agar, inset; (B) elution of a PG pentapeptide corresponding to a S. aureus PG
precursor fragment and corresponding test for quiescence reversal, inset; (C) Candidate
proliferants including NAG (0.4 mM), NAM (0.4 mM) and NAG-NAG (1 mM) were
tested for their ability to stimulate quiescent JJ1886 cells (103 CFU per plate) on 0.2%
glucose M9 minimal agar plates and plates were incubated for 24 h at 37 °C. White
arrows indicate position of proliferant addition and scale bars are 1 cm in length. Images
shown are representative of at least three independent replicates.
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FIG S7 E. coli peptidoglycan fragment analysis by tandem mass spectrometry. Tandem
mass spectrometry profiles showing total ion counts (TIC) for (A) crude peptidoglycan
extracted from E. coli and extracted ion counts (XIC) for fragments from digested E.
coli peptidoglycan and including LCMS/MS fragmentation for (B, E) disaccharide
tetrapeptide 940.396 [M+H]+ (m/z), (C, F) disaccharide tripeptide 869.364 [M+H]+
(m/z), and (D, G) disaccharide dipeptide 697.277 [M+H]+ (m/z).
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FIG S8 Analysis of quiescence stimulation by PG tetra- and pentapeptides. E. coli
peptidoglycan tetrapeptide was generated in situ by digestion of disaccharide
tetrapeptide with purified AmiD. (A) AmiD as purified by IMAC and analyzed by SDSPAGE. (B) AmiD, disaccharide tetrapeptide, and AmiD-digested disaccharide
tetrapeptide, which released NAG-NAM and tetrapeptide, were tested for the ability to
stimulate proliferation of quiescent JJ1886, JJ1886 DoppABCDF, and JJ1886 DmppA
cells plated at 103 CFU on M9 minimal agar with 0.2% glucose or (C) quiescent CFT073
cells plated at 104 CFU onto M9 minimal agar with 0.2% glucose and incubated for 48
h. (D) Pentapeptide (L-Ala-D-Glu-L-Lys-D-Ala-D-Ala) (5 μg) with similarity to a S.
aureus PG precursor peptide was tested for the ability to stimulate proliferation of
quiescent JJ1886, JJ1886 DoppABCDF, and JJ1886 DmppA cells plated at 103 CFU on
M9 minimal agar with 0.2% glucose and incubated for 24 h at 37 °C. Where indicated,
brackets highlight areas of stimulated colony growth and white arrows show position of
stimulant addition. Scale bar is 1 cm in length. Images shown are representative of at
least three independent replicates.
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TABLE S1 Monoisotopic masses of peptidoglycan fragments identified in this study
Peptidoglycan fragment

Observed
mass (Da)

Calculated
Mass (Da)

Disaccharide tetrapeptide
(NAG-NAM-L-Ala-D-Glu-mDap-D-Ala)

[M+H]+

940.396

940.400

Disaccharide tripeptide
(NAG-NAM-L-Ala-D-Glu-mDap)

[M+H]+

869.364

869.363

Disaccharide dipeptide
(NAG-NAM-L-Ala-D-Glu)

[M+H]+

697.277

697.278

Disaccharide
(NAG-NAM)

[M+K]+

535.128

535.154

Tetrapeptide
(L-Ala-D-Glu-mDap-D-Ala)

[M+H]+

462.198

462.220
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Abstract
When bacterial cells divide, a large cytoskeletal structure called the Z-ring
assembles at the division site. The major protein constituting the Z-ring is FtsZ, a tubulin
homolog and GTPase that utilizes nucleotide to assemble into dynamic polymers. In
Escherichia coli, many cell division proteins interact with FtsZ and modulate Z-ring
assembly, while others direct cell wall insertion and remodeling. Here, we show that
ZapE, an ATPase that accumulates during late constriction, directly interacts with FtsZ
in biochemical assays, and the interaction is independent of ZapE nucleotide hydrolysis.
We demonstrate that binding of ZapE to FtsZ stimulates large protein complexes to
form in GTP-dependent FtsZ polymerization assays, suggesting that ZapE may bundle
FtsZ polymers. Further, deletion of zapE induces a mild filamentation phenotype in cells
grown under nutrient rich conditions. However, in cells deleted for zapE in combination
with minC, we observed a slow growth phenotype in response to mild heat shock. This
synthetic phenotype suggests that in the absence of minC, which negatively regulates
FtsZ polymerization, cells are more reliant on ZapE for efficient proliferation. Our
results demonstrate that ZapE binds directly to FtsZ and regulates E. coli cell division
after exposure to thermal stress.
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Importance
Widespread antibiotic usage has already led to the emergence of bacterial resistance to
b-lactam drugs and vancomycin (1–5). Understanding the mechanisms in which
bacteria, specifically E. coli, regulate cell division will give us better insight into future
antibiotic targets. ZapE is a conserved Z-ring associated protein that is found in other
Gram-negative pathogenic bacteria, including Shigella flexneri, where ZapE is required
for infection of the gastrointestinal tract (6). Notably, ZapE is the first FtsZ-associated
protein to be detected at the Z-ring during constriction, which suggests that it may
function to influence FtsZ polymer assembly late in the cell cycle (6).

Keywords:
Cell division, FtsZ, ZapE, Z-ring associated protein, AAA+ ATPase, Escherichia coli
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INTRODUCTION
Proliferation via the cell division pathway requires more than 30 different
proteins acting in a well-coordinated manner (7). Even though most of the individual
proteins involved have been characterized, knowledge of their functional interactions
remain incomplete (8). In E. coli and most bacteria, cell division is mediated by the
highly conserved tubulin-like FtsZ protein (9). FtsZ is a GTPase, and binding of GTP
to FtsZ protomers leads to the formation of linear protofilaments (10). FtsZ
protofilaments comprise the Z-ring at midcell during constriction, and may act as a
scaffold for assembly of the divisome (10) .
FtsZ assembly and the dynamic nature of the Z-ring is regulated by several FtsZinteracting proteins. For example, Z-ring associated proteins (Zaps), including Zap(AD) are recruited early in the cell division process and regulate the development of the
Z-ring (11). ZapE, which has been recently characterized as a Z-associated protein,
although not structurally related, is an AAA+ ATPase containing both Walker A
78(GGVGRGKT)85

and Walker B 141(CFDEF)145 nucleotide-binding sites (6). Purified

E. coli His-tagged ZapE was reported to hydrolyze ATP but not GTP in vitro; however,
the rate was not determined (6). Furthermore, when assessed by silica layer
chromatography, an amino acid substitution in the ATP-binding site of ZapE at position
84, from lysine to an alanine, ZapE(K84A), displayed reduced ATPase activity (6).
ZapE is a late stage cell division protein that was reported to co-localize with
FtsZ at midcell in vivo and influence FtsZ polymerization in vitro (6). Like the other
Zaps which have a positive effect on FtsZ polymerization and stability, usually through
direct binding, bundling, and decreasing FtsZ subunit exchange by slowing down the
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GTPase activity of FtsZ (12–16), we designed in vitro experiments to elucidate if ZapE
had an effect on FtsZ polymer dynamics.
Another AAA+ ATPase that has also been shown to influence FtsZ polymer
assembly is ClpX (17, 18). ClpX forms the two-component bacterial proteasome
complex along with ClpP, a serine protease. The ClpXP complex processively degrades
specific protein substrates, including FtsZ, after initiating ATP-dependent unfolding
from the N- or C-terminus. During E. coli division, ClpXP degradation of polymerized
FtsZ modifies the dynamic exchange of FtsZ subunits in the Z-ring by a polymer
severing mechanism (17–19). Though also a member of the AAA+ family of ATPdependent remodeling proteins, it is unclear if ZapE also destabilizes FtsZ polymers by
a similar severing mechanism as ClpXP.
Previously an interaction between FtsZ and ZapE was suggested, and ATP
hydrolysis was proposed to be nonessential for this interaction (6). To gain mechanistic
insight into the functional interaction between ZapE and FtsZ we first purified and
quantified the ability of ZapE, and the hydrolysis defective mutant, ZapE(K84A), to
hydrolyze ATP. Next, we showed a direct interaction between ZapE and FtsZ through
biochemical assays. Additionally, we show that ZapE can bind to both unpolymerized
and polymerized FtsZ, in vitro. Further, our results indicate ZapE can directly interact
with FtsZ, and ZapE increases the light scatter caused by FtsZ in GTP-dependent FtsZ
polymerization assays, suggesting ZapE is behaving as an FtsZ bundler. Moreover, we
show that the protein-protein interaction between ZapE and FtsZ, and the mechanism
by which ZapE increases the scatter of protein complexes is not dependent on the ability
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of ZapE to hydrolyze nucleotide and is independent of altering the GTPase activity of
FtsZ.
In E. coli, a deletion of zapE is defective for growth under low oxygen
conditions but has been reported to display no defect in an aerobic environment (6). An
increase in temperature (42 °C) in a zapE deletion strain generates a filamentous
phenotype suggesting involvement of ZapE in cell division. To further investigate the
role of ZapE during division, we constructed a zapE deletion strain to determine if the
absence of zapE leads to a change in average cell length indicating impaired cell
division. Cells deleted for zapE display a subpopulation of filamentous cells under
nutrient rich conditions in comparison to wild type. We further show strains
complemented with zapE or zapE(K84A), both prevent the formation of filamentous
cells indicating ZapE enzymatic function is not imperative for this effect. In addition,
strains deleted for zapE and minC, an FtsZ polymer inhibitor (20–22), are defective for
growth, while complementation with zapE or zapE(K84A) both restore growth as
reported by biomass. These results also demonstrate that ZapE optimal enzymatic
function is not required for restoration of growth.
Finally, our data suggest that, ZapE plays a significant role in regulating E. coli
cell division. In vitro, ZapE directly interacts with both polymerized and unpolymerized
FtsZ, and further influences FtsZ polymer dynamics, through ZapE nucleotide binding
and not hydrolysis. ZapE promotes FtsZ polymer bundling observed through an increase
in the scatter of protein complexes demonstrated in GTP-dependent FtsZ
polymerization assays. This evidence suggests that ZapE nucleotide binding may
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directly regulate FtsZ assembly in vivo, which ultimately is important for effective
cytokinesis.

RESULTS
Nucleotide-bound ZapE promotes the formation of large protein complexes with
FtsZ in GTP-dependent polymerization assays
ZapE has previously been reported to be a regulator of cell division in E. coli
(6). However, an in vitro interaction between FtsZ and ZapE was also proposed but ATP
hydrolysis was suggested to not be critical (6). To biochemically characterize ZapE, and
further understand how ZapE regulates division and interacts with FtsZ directly, we
purified N-terminally histidine-tagged ZapE and the putative hydrolysis mutant of
ZapE, ZapE(K84A), by metal affinity chromatography and then assayed the purified
proteins for enzymatic activity and direct interaction with FtsZ (Fig. 1A and Fig. S1A).
We monitored ATP hydrolysis in reactions containing 6 μM ZapE or ZapE(K84A) and
observed that ZapE hydrolyzes ATP at a rate of 2.22 ± 0.23 pmol Pi min-1 pmol-1 under
the conditions tested (Fig. 1B). No ATP hydrolysis was detected in reactions containing
ZapE(K84A) (Fig. 1B), consistent with a role for Lys 84 in hydrolysis. Next we titrated
substrate concentration from 0 mM to 5 mM in reactions containing 12 μM ZapE to
determine the maximal reaction velocity (Vmax). The Vmax plateaued at 1.1 ± 0.09 pmol
Pi min-1 pmol-1 with a Km of 1.7 ± 0.36 mM (Fig. 1C).

To determine the oligomeric state of ZapE, we fractionated ZapE by size
exclusion chromatography in the absence and presence of ATP, and calculated the size
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of ZapE to be ~39.0 kDa under both conditions (Fig. 1D, S1B, and S1C), which is
consistent with the calculated molecular mass of 44,583 Da. We detected no apparent
cooperativity upon titrating protein or substrate concentration in ATP hydrolysis assays
(Fig. 1C and S1D), consistent with ZapE functioning as a monomer in these assays.
Notably, we also constructed a C-terminally tagged six histidine fusion protein, but it
hydrolyzed ATP at an 86% slower rate (0.31 ± 0.02 pmol Pi min-1 pmol-1) than ZapE
with the N-terminal histidine tag, suggesting that addition of a tag sequence to the Cterminus of ZapE interferes with enzymatic activity (Fig. S1E).

ZapE was previously suggested to influence FtsZ polymerization in qualitative
fluorescence-based microscopy assays in vitro (6). To monitor the effects of ZapE on
FtsZ polymerization in vitro, we used 90° light scattering to detect GTP-dependent
polymerization. First, we assembled FtsZ (8 μM) in the presence and absence of ZapE
(8 μM) and ATP (4 mM) and incubated the reaction mixture at room temperature for 5
min to collect a baseline. We then added GTP (1.5 mM) to induce polymerization and
monitored the change in light scatter with time, which has been reported to correspond
to the accumulation of FtsZ polymers after addition of GTP (Fig. S2A) (18). In control
assays without addition of GTP, no increase in light scatter was detected. Next, we preincubated FtsZ (8 μM) with increasing amounts of ZapE (0 μM to 8 μM), in the presence
of ATP (4 mM) for 5 min, added GTP (1.5 mM), and monitored the change in light
scatter with time (Fig. 2A). We observed that as ZapE concentration increases, so does
the amount of light scatter over time, as well as the maximum intensity recorded, with
a 130% increase in maximum light scatter comparing ZapE (0 μM) and ZapE (8 μM)
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(Fig. 2A and 2B). Under the condition tested, ZapE does not scatter light in the absence
of FtsZ (Fig. S2A), suggesting that addition of ZapE to FtsZ polymerization reactions
increases the scatter of protein complexes containing ZapE and FtsZ.

To determine if ATP is necessary for the observed increase in light scatter by
ZapE in FtsZ polymerization reactions, we repeated the assay without ATP. We did not
detect an increase in the scattering of light when ATP was omitted from FtsZ
polymerization reactions containing ZapE (Fig. 2C). Next, we tested ADP (2 mM) and
the non-hydrolyzable analogue ATPgS (2 mM) in ZapE and FtsZ 90° light scattering
polymerization assays (Fig. 2C). Both nucleotide conditions resulted in an increase in
GTP-dependent light scatter detected in reactions containing FtsZ and ZapE, and
omission of ATP did not result in increased scatter by ZapE (Fig. 2C). Finally, we also
tested if ZapE(K84A) increases light scatter in GTP-dependent FtsZ polymerization
assays and observed an increase similar to wild type ZapE with ATP (Fig. 2D). These
results suggest that nucleotide-bound ZapE forms complexes with FtsZ detected in
GTP-dependent polymerization assays, and further, strongly indicates a direct
interaction between FtsZ and ZapE.

To characterize the interaction between ZapE and FtsZ and determine if ZapE
binds to unpolymerized and/or polymerized FtsZ, we performed dot blot assays. We
began by fixing FtsZ onto a nitrocellulose membrane, added ZapE in solution to allow
for potential binding, and then probed for ZapE retention using a ZapE antibody.
Briefly, bovine serum albumin (BSA) (10 μM), ZapE (10 μM), FtsZ (10 μM), FtsZ (10
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μM) with GDP (2 mM), and FtsZ (10 μM) with GTP (2 mM) were applied in a 10 μl
spot to a nitrocellulose membrane, allowed to dry, and blocked with BSA. A solution
of ZapE (8 μM) with ATP (4 mM) was incubated with the membrane to allow for
potential binding. Binding was then probed with a ZapE antibody. Our results show that
ZapE binds to FtsZ under all conditions tested and ZapE does not bind to the control
BSA (Fig. 2E). These results suggest that ZapE binds to both the unpolymerized and
polymerized states of FtsZ.

To collect complexes containing ZapE and FtsZ, we performed ultrafiltration
assays on a polyethersulfone filter with a 100-kDa exclusion limit. To analyze retained
proteins and differentiate ZapE from FtsZ by SDS-PAGE, since they migrate similarly,
we utilized the chimeric fusion protein Gfp-FtsZ. Gfp-FtsZ, which has a molecular
weight of 68 kDa, was previously been shown to polymerize, hydrolyze GTP, and
behave similarly to wild type FtsZ in in vitro assays and assemble into a Z-ring in vivo
(17). In the presence of Gfp-FtsZ (10 μM) and ATP (4 mM), 63.4% of the total ZapE
in the reaction (5 μM) was retained, whereas only 33.4% of ZapE was retained when
Gfp-FtsZ was omitted, suggesting that ZapE forms a complex with FtsZ (Fig. S2B). The
amount of ZapE retained did not change in the presence of GTP, which promotes
polymerization, suggesting that ZapE binds similarly to non-polymerized and
polymerized Gfp-FtsZ (Fig. S2B). Finally, to determine if ATP hydrolysis is required
for complex formation between ZapE and FtsZ, we performed ultrafiltration assays with
ZapE(K84A) (5 μM) co-incubated with FtsZ (10 μM) with ATP (4 mM) and also
observed that Gfp-FtsZ retained ZapE(K84A) at a higher value (80.2%), in comparison
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to ZapE(K84A) alone 50.3% (Fig. S2C), suggesting that ZapE nucleotide hydrolysis is
not required for Gfp-FtsZ binding.

Lastly, to determine if ZapE modulates the GTPase activity of FtsZ, like other
proteins reported to bundle FtsZ polymers (12–16, 23), we measured the rate of GTP
hydrolysis in reactions containing FtsZ (6 μM) in the absence and presence of ZapE (12
μM). The GTP hydrolysis rate of FtsZ was determined to be 1.00 ± 0.28 pmol Pi min-1
pmol-1, and the rate did not significantly change in the presence of ZapE 1.13 ± 0.31
pmol Pi min-1 pmol-1 (Fig. 2F). Additionally, ZapE is unable to use GTP as a substrate
(data not shown). We also tested if FtsZ modifies ZapE ATPase activity but detected no
change in the rate of ATP hydrolysis for either (Fig. S2D).

E. coli cells deleted for zapE display a mild filamentous phenotype.
ZapE was reported to be an ATPase required for cell division in E. coli under
low-oxygen conditions, and deletion of zapE leads to cell elongation in cultures grown
at high temperature (42 °C) (6). First, to determine if ZapE is important during log phase
growth in liquid LB(Lennox) medium, we cultured cells and performed microscopy to
determine if cells were delayed for division and filamentous. Cultures of MG1655 and
MG1655 DzapE were grown for 3 h at 35 °C to an OD600 of approximately 0.8 (Fig. S3)
and analyzed by differential interference contrast (DIC) microscopy. E. coli MG1655
cells were short rods, with a mean length of 2.78 ± 0.53 μm (n = 200); however, cultures
of MG1655 ΔzapE had a mean cell length of 3.86 ± 6.15 (n = 200), which is 38.8%
longer than wild type cells (Fig. 3A and Fig 3B), with a small population (7%) of
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filamentous cells longer than 5 μm. To determine if ZapE ATP hydrolysis is required to
support normal division, we constructed a strain expressing ZapE(K84A) from the
native locus on the chromosome by replacing a cassette at the original locus with zapE
or zapE(K84A). We performed microscopy on cells in log phase and determined that
both strains had a cell length distribution similar to wild type cells (MG1655) and no
filamentous cells were observed (Fig. 3C). Additionally, MG1655 ΔzapE::zapE cells
were observed to have a mean length of 2.26 ± 0.55 (n = 200), and MG1655
ΔzapE::zapE(K84A) cells were observed to have a mean length of 2.31 ± 0.60 (n = 200)
(Fig. 3D). These results suggest deletion of zapE leads to a cell division defect in E.
coli, and that ATP hydrolysis does not appear to be important for this function.

Deletion of zapE leads to a synthetic slow growth phenotype in a minC deletion
strain.

MinC is a cell division regulator that functions in the cell to prevent assembly
of the Z-ring near the cell poles by actively disassembling FtsZ polymers (20–22, 24)
SlmA and ClpXP also disassemble FtsZ polymers in vitro (18, 19, 25–27). Deletion of
SlmA causes a synthetic lethal phenotype in a min deletion strain (25), and deletion of
either clpX or clpP leads to a synthetic filamentous phenotype in a minC deletion strain
(28). We hypothesized that if ZapE were also functioning to influence the FtsZ
polymeric state, then the cell may rely more on ZapE function in the absence of minC.
We constructed a strain deleted for both minC and zapE by lambda Red recombineering
(Table 1) and tested for cell growth under several conditions. In liquid, rich medium
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(LB broth), at an optimal temperature of 37 °C, we observed no growth delay (Fig. S4A)
and no difference in OD600 of MG1655 wild type and deletion strains MG1655 ΔzapE,
ΔminC, and ΔminC ΔzapE (Fig. S4B).

Since ZapE is reported to be important for growth in E. coli under elevated
temperatures (6), we tested if mild heat shock was sufficient to induce a requirement for
zapE by exposing stationary phase cells to 42 °C for 3 h in static cultures, and then
spotted dilutions onto LB agar plates (Fig. 4A). After incubating the plates for 45 h at
23 °C, we observed that deletion of either minC or zapE only had minor effects on cell
growth and colony formation, however, deletion of both zapE and minC together
reduced overall colony biomass by 49.5%, compared to wild type MG1655 (Fig. 4B and
4C). Further, the strains tested demonstrated similar OD600 measurements under the mild
heat shock conditions (Fig S4C). These results suggest that after exposure to heat shock,
cells deleted for zapE and minC are less able to resume normal growth and experience
a growth delay on solid medium. Next, we reinserted zapE or zapE(K84A) genes back
into the chromosome at the native locus to construct MG1655 ΔminC ΔzapE::zapE and
ΔminC ΔzapE::zapE(K84A), respectively. Restored strains were cultured in liquid
medium, exposed too mild heat shock, as described, and monitored for growth on agar
plates. We observed that both strains grew more robustly than the minC zapE double
deletion strains (Fig. 4A, 4B, and 4C), and had similar OD600 measurements under all
conditions tested (Fig. S4B and Fig. S4C). Our results suggest that ZapE ATP hydrolysis
is not required to support recovery after heat shock in the minC deletion strain.
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DISCUSSION
Here we report, that FtsZ polymers, as well as unassembled FtsZ, bind directly
to ZapE in vitro. ZapE is an AAA+ ATPase that hydrolyzes nucleotide and, in our study,
we show ZapE is a monomer with and without ATP under the conditions tested (Fig.
5A and Fig. 5B). ZapE shows sequence homology to other AAA+ ATPases (i.e., DnaA
and VCP/p97) (29–33). Most AAA+ ATPases (i.e., ClpX) form hexamers, which are
stabilized when bound to nucleotide (34), with further notable example VCP/p97 (29,
30, 32, 33). Although less common, there are several examples of AAA+ proteins that
have been shown to be monomeric [i.e., cell division control protein 6 (Cdc6) (35),
which is an essential regulator of DNA replication in eukaryotes].

We also show that ZapE increases the light scatter produced by FtsZ polymers,
suggesting that ZapE promotes FtsZ polymer bundling. Other Zaps (A-D) also interact
with FtsZ and influence bundling of FtsZ protofilaments, although the Zaps are not
structurally related. ZapA interacts directly with FtsZ (36, 37), while ZapB does not,
but is recruited to midcell by ZapA and enhances the activity of ZapA to promote FtsZ
filament bundling (38–40). In vitro, ZapA forms a tetramer, and cross-links FtsZ
polymers, while reducing the GTPase activity of FtsZ (12–14). ZapC also promotes the
bundling of FtsZ polymers and inhibits FtsZ GTP hydrolysis (15). A deletion of zapC
shows a minor cell elongation phenotype, which is exacerbated by additional deletions
in zapA or zapB, further suggesting a role for ZapC in Z-ring stability (15, 16). In vitro,
ZapD cross-links FtsZ polymers and reduces the GTPase activity of FtsZ (16). Deletion
of zapD alone confers no defect in viability, however, in combination with temperature
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sensitive mutation in the ftsZ gene, ftsZ(G105S), deletion of zapD leads to filamentation
and a decrease in viability, suggesting the role of ZapD as a regulator of FtsZ (16).

While ZapA, ZapC, and ZapD all bundle FtsZ, leading towards a reduction in
the rate of FtsZ GTP hydrolysis, we detected no decrease in FtsZ GTP hydrolysis
activity in the presence of ZapE, potentially suggesting a novel mechanism for FtsZ
polymer bundling or crosslinking in E. coli. Notably, the Staphylococcus aureus cell
division protein, GpsB, directly binds to FtsZ, promotes FtsZ polymer bundling, and
unusually, stimulates the GTPase activity of FtsZ (23). It has been hypothesized that the
purpose of GpsB induced FtsZ bundling is to increase the local abundance of FtsZ,
which ultimately stimulates the GTPase activity of FtsZ, influencing Z-ring dynamics
(23).

AAA+ ATPases have two fundamental regions important for ATP binding and
subsequent hydrolysis, Walker-A and Walker-B motifs (41). The conserved sequence
GXXXXGK(T/S) (X representing any amino acid), represents the essential P-loop of
the Walker-A motif, which is needed to directly interact with the phosphate of the ATP
molecule (42). Specifically, the L-lysine (K) residue is crucial for this interaction and is
predicted to be at the 84th position of ZapE (6). We have demonstrated that mutant
protein ZapE(K84A) is defective for enzymatic function in vitro. Most AAA+ ATPases
go through conformational changes related to ATP binding and/or hydrolysis, which is
essential to the overall function of the protein, and these changes can even be
communicated to their substrates (42). Detection of differential structural conformations
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can be obtained through cryo-electron-microscopy analysis, X-ray crystallography, and
small-angle X-ray scattering (43). An example of a AAA+ ATPase that has been shown
to undergo different conformational states is p97/VCP. Specifically, the N-domain of
p97/VCP, is required for cofactor and/or substrate binding, and has been demonstrated
to alter in position upon varying nucleotide-bound states (44–46). In this study, we
report that ZapE nucleotide binding is required to promote bundling of FtsZ polymers
in GTP-dependent polymerization assays (Fig. 5B) but not hydrolysis. This mechanistic
insight was elucidated through 90° light scattering assays utilizing different nucleotides.
For example, the non-hydrolyzable ATP analogue, ATPgS, which supported FtsZ
bundling by ZapE, detected by a dramatic increase in light scatter. Further, we utilized
the hydrolysis defective mutant, ZapE(K84A), which also promoted FtsZ bundling, and
behaved similar to wild type.

In E. coli, deletion of zapE was previously reported to produce an elongated cell
phenotype under low oxygen or elevated temperature (42 °C) (6). Our study also
demonstrated conditions in which deletion of zapE generated a subpopulation of
filamentous cells, consistent with previous reports; however, it is unclear why there is
heterogeneity in the length of filamentous cells in the population. This result supports
the role of ZapE as a cell division regulator. Furthermore, we also observed a synthetic
slow growth phenotype in cells deleted for minC and zapE after exposure to mild heat
shock, which is more severe than a deletion of either gene individually. Synthetic
phenotypes have also been observed in other strains when minC was deleted in
combination with slmA (synthetic lethal) or clpX (synthetic filamentous) (25, 28). MinC
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spatially regulates placement of the Z-ring in vivo by preventing Z-ring assembly near
the cell poles (20–22, 24). These results establish that when division site selection is
impaired by deletion of minC, other FtsZ-assembly regulators including ZapE are
important for promoting division.

Lastly, our in vitro data has not identified interactions that require ATP
hydrolysis by ZapE, per se; however, the ZapE-FtsZ interaction requires ATP binding
and zapE(K84A), which encodes a protein defective for hydrolysis, complements the
observed growth defects in vivo. These results raise the question, why does ZapE
hydrolyze nucleotide and how is this linked towards regulating division? Our current
model depicts ZapE directly interacting with FtsZ, and when ZapE binds nucleotide,
this potentially alters the conformational state of ZapE, and as a result ultimately
promotes FtsZ polymer stability and bundling. ZapE is recruited late to the divisome
and correlates with constriction (6). Stabilizing FtsZ polymers late in the cell division
process could serve as an additional means of regulation that along with other FtsZ
polymerization regulators modulate the intricate balance between assembly and
disassembly of FtsZ polymers required for constriction and septation. Further studies
should be directed at characterizing the direct interaction sites between ZapE and FtsZ
to further elucidate the role of ZapE in regulating FtsZ assembly and Z-ring function.
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MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions
E. coli strains, (Table 1), were grown in LB (Lennox), Luria-Bertini broth with
NaCl 5 g/L, media and/or LB (no salt) media and agar. (47), plus ampicillin (100 μg/ml),
or kanamycin (50 μg/ml), when necessary. Gene deletions were constructed by λ-red
recombination as described in Datsenko and Wanner, 2000 (48). Culture densities were
monitored and measured by OD600. DIC microscopy was performed with MG1655 and
constructed mutants. For protein purification, zapE and zapE(K84A), were constructed
by site-directed mutagenesis, and cloned into pET-28a expression vector with a Nterminal 6x-histidine tag.

Protein expression and purification
Vectors containing zapE and zapE(K84A) with an N-terminal 6x-histidine tag
were transformed and overexpressed in E. coli BL21 (λde3). Cell cultures were grown
to an OD600 of 0.8 and induced with IPTG (0.5 mM) for 4h at 30 °C. Cultures were
centrifuged, and pellets were lysed by french press in 25 mM Tris (pH 7.5) buffer
containing 0.1 mM TCEP, 10 mM MgCl2, 150 mM KCl, and 10% glycerol. Soluble cell
extracts were collected by centrifugation at 35,000 x g for 30 min, applied to an IMAC
column and eluted with an imidazole gradient. Protein lysis buffer was exchanged to
remove imidazole. Native FtsZ was expressed in E. coli BL21 (λde3) and purified as
described in Camberg et al., 2009, using ammonium sulfate precipitation and ion
exchange chromatography (18). Gfp-FtsZ was expressed in E. coli BL21 (λde3) and
purified as described in Viola et al., 2017, by applying soluble cell extracts to an IMAC
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column and eluting with an imidazole gradient (17). Protein lysis buffer was exchanged
to remove imidazole.

Nucleotide hydrolysis assays
Nucleotide hydrolysis (GTP or ATP) of purified proteins was assayed using the
Biomol Green phosphate detection reagent (Enzo Life Sciences) as described in
Camberg et al., 2014 (19), to detect the release of free phosphate by colorimetric
phosphate quantitation relative to a phosphate standard curve over time (abs. 655 nm).

Size exclusion chromatography assays
Purified H6-ZapE was applied to analytical size exclusion chromatography
column to assess size/oligomeric state, as described in Conti et al., 2018 (49). H6-ZapE
was incubated at room temperature with or without ATP (5 mM) for 5 min and then
passed through a Sephacryl S-200 (25 mL) column with 25 mM Tris (pH 7.5) buffer
containing 0.1 mM TCEP, 10 mM MgCl2, 150 mM KCl and 10% glycerol, with or
without ATP (0.5 mM). The column was standardized using known molecular weight
proteins. Eluting protein fractions were analyzed by the Bradford protein assay (50),
and visualized by SDS-PAGE and Coomassie staining.

Light scattering assays
90° angle light scattering was performed in FtsZ assembly buffer, and where
indicated, reaction mixtures (80 μL) containing ZapE (2 – 8 μM) or ZapE(K84A) (4
μM), with or without FtsZ (8 μM), was monitored using an Agilent Eclipse fluorescence

151

spectrophotometer with both excitation and emission wavelengths set to 450 nm with 5
nm slit widths, as described Conti et al., 2018 (49). Protein reactions were incubated at
room temperature for 5 min, and where indicated, with ATP (4 mM), ADP (2 mM), or
ATPgS (2 mM). Baseline readings were collected for 5 min, GTP (1.5 mM) was added,
and light scattering was measured at 23 °C, for up to 40 min, where indicated.

Dot blot assays
Bovine serum albumin (BSA) (10 μM), ZapE (10 μM), FtsZ (10 μM), FtsZ (10
μM) with GDP (2 mM), and FtsZ (10 μM) with GTP (2 mM) were spot plated (3 μL)
and fixed onto a nitrocellulose membrane, allowed to dry, and blocked with BSA (2%).
The membrane was then washed with Tris-buffered saline with 0.1% Tween® 20
detergent (TBST). ZapE (8 μM) with ATP (4 mM) in 50 mM HEPES (pH 7.5) optimal
ZapE nucleotide hydrolysis buffer (150 mM KCl and 20 mM MgCl2) was incubated at
room temperature for 1 h with the membrane to allow for potential binding. The
membrane was washed again in TBST and ZapE binding was then probed with
antibodies directed against ZapE. Anti-ZapE antiserum was generated in rabbits using
purified H6-ZapE (ThermoFisher). The membrane was then developed by
chemiluminescence, densitometry performed, and analyzed by ImageJ.

Filter retention assays
ZapE (5 μM), ZapE(K84A) (5 μM), and/or Gfp-FtsZ (10 μM) reaction mixtures
(40 μL), in assembly buffer containing 50 mM MES (pH 6.5), 100 mM KCl, and 10
mM MgCl2, were incubated with ATP (4 mM) and where indicated GTP (2 mM) at
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room temperature for 10 min. Reactions were filtered through 100 kDa Omega
(modified polyethersulfone) filters by centrifugation at 16,900 x g for 20 min.
Flowthrough proteins were analyzed by SDS-PAGE and Coomassie staining, and
densitometry was performed using NIH ImageJ software. Comparisons were
quantitated using the concentration of protein loaded vs protein retained.

Microscopy
MG1655,

MG1655

ΔzapE,

MG1655

ΔzapE::zapE,

and

MG1655

ΔzapE::zapE(K84A) strains were grown overnight in LB(Lennox) media at 30 °C. The
next day cultures were diluted into fresh LB(Lennox) media and standardized to 0.05
OD600, grown for 3 h at 35 °C, and OD600 measured. Cells were then harvested by
centrifugation at 3,000 x g for 5 min, resuspended in 100 µL of 1x PBS with EDTA (1
mM) and fixed to glass slides with poly-L-lysine-coated coverslips. Cells were imaged
by DIC microscopy using a Zeiss AxioCam HRc high-resolution camera, processed
using Adobe photoshop CS6, and measured using ImageJ software.

Growth assays
MG1655, MG1655 ΔzapE, MG1655 ΔminC, MG1655 ΔminC ΔzapE, MG1655
ΔminC ΔzapE::zapE, and MG1655 ΔminC ΔzapE::zapE(K84A) strains were grown
overnight in LB(Lennox) media at 30 °C. The next day cultures were diluted into fresh
LB(no salt) or LB(Lennox) media, standardized to an OD600 of 0.05 and grown for 3 h
under mild heat shock conditions: LB(no salt), static, and 42 °C, or as a control, under
optimal conditions: LB, shaking (250 rpm), and 37 °C. Growth was measured by OD600,
after the allotted time, and cultures were 2-log diluted into LB(no salt) media. Dilutions
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were spot plated (5 μL) onto LB(Lennox) or LB(no salt) agar and plates were incubated
at room temperature for 45 h, images were taken, processed using Adobe photoshop
CS6, and analyzed using ImageJ software.

SUPPLEMENTAL MATERIAL
Supplementary information is available for this paper.
FIG S1, S2, S3, S4
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FIG 1 ZapE(K84A), which possesses a mutation in a predicted loop near the active site,
is defective for function in vitro. (A) Structural model of E. coli ZapE residues (51-275)
modeled onto DnaA (pdb 2Z4R) (Ozaki et al., 2008) ADP blue, Mg2+ gold, residue K84
green. (B) Hydrolysis of ATP (4 mM) by ZapE (6.0 μM) and ZapE(K84A) (6.0 μM)
was monitored with time (0, 2.0, 4.0, 6.0, and 8.0 min) and phosphate released (pmol)
reported. (C) ZapE (12 μM) hydrolysis rates with increasing ATP concentrations (0,
0.25, 0.5, 0.75, 1.0, 2.0, 3.0, 4.0, and 5.0 mM) reported as pmol Pi min-1 pmol-1. (D) An
elution profile of ZapE by size exclusion chromatography where each 0.25 mL fraction
(5 – 25 mL) was tested for protein concentration represented by Intensity (A.U.), at a
wavelength of 595 nm, using Bradford reagent detection, as described in Methodology.
Data from (B and C) are an average of three replicates represented as mean ± SEM.
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FIG 2 ZapE directly binds to FtsZ and promotes an increase in complex formation in
the presence of nucleotide in FtsZ GTP-dependent polymerization experiments. (A, B,
C, and D) GTP-dependent assembly of complexes containing FtsZ was monitored by
90° light scattering, as described in Methodology. Protein mixtures (ZapE,
ZapE(K84A), and/or FtsZ) were co-incubated with nucleotide (ATP, ADP, or ATPgS)
for 5 min. Light scattering was monitored as a function of intensity (A.U.) over time. A
baseline was collected for 5 min, GTP (1.5 mM) was added to stimulate complex
formation and detection was measured for 40 min at room temperature. (A) Light
scattering assay showing reactions containing FtsZ (8.0 μM), ZapE titration (0, 2.0, 4.0,
and 8.0 μM) and ATP (4 mM). (B) Light scattering assay showing maximum intensity
(A.U.) values for reactions containing FtsZ (8.0 μM), ZapE titration (0, 2.0, 4.0, and 8.0
μM) and ATP (4 mM). (C) Light scattering assay showing reactions containing FtsZ
(8.0 μM), ZapE (8.0 μM) with varying nucleotide ATP (4 mM), ADP (2.0 mM), ATPgS
(2.0 mM) and ATP omission. (D) Light scattering assay showing reactions containing
FtsZ (8.0 μM), ATP (4 mM) and ZapE (4.0 μM), ZapE(K84A) (4.0 μM), or ZapE
omission. (E) Dot blot assay, as described in Methodology, involving reactions of BSA
(10 μM), FtsZ (10 μM), FtsZ (10 μM) with GDP (2 mM), and FtsZ (10 μM) with GTP
(2 mM), or ZapE (10 μM). Protein was fixed onto a nitrocellulose membrane,
challenged with a mixture of ZapE (8 μM) and ATP (4 mM), probed with antibodies
directed against ZapE, developed by chemiluminescence, densitometry performed, and
analyzed by ImageJ. (F) GTP hydrolysis assay of FtsZ (6 μM) or ZapE (12 μM) and
FtsZ (6 μM), both with GTP (2 mM), represented by pmol Pi min-1 pmol-1. Data shown
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in (A, B, C, D, and F) is representative of three, (E) two, replicates. (B, E, and F) are
represented as mean ± SEM.
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FIG 3 Cell morphology of E. coli strains deleted for zapE and restored with zapE or
zapE(K84A) PCR products. Log-phase cultures of (A) MG1655, MG1655 ΔzapE, (C)
MG1655 ΔzapE::zapE and MG1655 ΔzapE::zapE(K84A) grown at 35 °C in LB were
added to poly-L-lysine-coated coverslips and observed by DIC microscopy. Size bar, 5
μm. Cell length distribution of (B) MG1655 and MG1655 ΔzapE (D) MG1655
ΔzapE::zapE and MG1655 ΔzapE::zapE(K84A) (n = 200 cells for each).
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FIG 4 Biomass of E. coli strains deleted for zapE, in a ΔminC background, and restored
with zapE or zapE(K84A) PCR products. (A) Dilution (2-log) of cultures MG1655,
MG1655 ΔzapE, MG1655 ΔminC, MG1655 ΔminC ΔzapE::kan, MG1655 ΔminC
ΔzapE::zapE(K84A) and MG1655 ΔminC ΔzapE::zapE were spotted (5 μL) on LB(no
salt) agar and grown as described in Methodology. (A) Plates were incubated for 45 h
at room temperature, images were taken, and (B) analyzed by densitometry. (C)
Biomass quantified by surface plot (ImageJ) and plotted as a function of integrated spot
density after 45 h. Data is an average of five replicates represented as a box and whiskers
plot. (p-values are as follows, ‘*’ < 0.05 and ‘**’ < 0.01).
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FIG 5 Model of ZapE directly interacting with FtsZ and influencing FtsZ GTPdependent polymerization. Model of ZapE residing as a monomer, (A) directly binding
to both the unpolymerized and GTP-dependent polymerized state of FtsZ in vitro. (B)
ZapE, bound to nucleotide, binds to free FtsZ and promotes stability and bundling of
FtsZ polymers in vitro. ZapE ATP hydrolysis is not necessary for the effect on FtsZ
polymerization.
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TABLE 1 E. coli strains and plasmids used for genetic analyses and constructions in
this study
E. coli
Strain or
Plasmid
Strains

Relevant
Genotype
Description

Identifier

Source, reference or
construction

MG1655

LAM-rph-1

MG1655

(51)

BL21 (λde3)

BL21 (λde3)

EMD Millipore,
USA

ED0011
JC0232

F- ompT gal dcm lon
hsdSB(rB- mB-) λ(de3[lacI
lacUV5-T7 gene 1 ind1
sam7 nin5])
MG1655 DzapE::parE-kan
MG1655 ΔminC::frt

MG1655 DzapE
MG1655 ΔminC

MG1655; λred
(28)

ED0024

MG1655 ΔminC::frt
ΔzapE:: pare-kan

MG1655 ΔminC
ΔzapE

MG1655
ΔminC::frt; λred

ED0118

MG1655 ΔminC::frt
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kan, His6-zapE(K84A)

This study
This study
This study
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J. Teramoto, K. A. Datsenko, and B. L. Wanner, unpublished construction
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FIG S1 ZapE hydrolyzes ATP. (A) ZapE and ZapE(K84A) purified by IMAC and
analyzed by SDS-PAGE. (B) An elution profile of ZapE with ATP by size exclusion
chromatography where each 0.25 mL fraction (5 – 25 mL) was tested for protein
concentration represented by Intensity (A.U.), at a wavelength of 595 nm, using
Bradford reagent detection, as described in Methodology. (C) ZapE, and where
indicated, with and without ATP, size exclusion chromatography fractions (15.5 – 22.0
mL, by 0.5 mL titration) analyzed by SDS-PAGE. (D) Hydrolysis of ATP (4 mM) by
ZapE titration (0, 3.0, 6.0, 12.0, 18.0, and 24.0 μM) and assayed for free phosphate as
described Methodology. (E) Hydrolysis of H6-ZapE (12 μM) and ZapE-H6 (12 μM)
represented by pmol Pi min-1 pmol-1. Data from (D and E) is an average of three
replicates represented as mean ± SEM.
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FIG S2 Biochemical assays characterizing the direct interaction between ZapE and
FtsZ. (A) GTP-dependent assembly of complexes containing ZapE (8 μM), FtsZ (8 μM),
or FtsZ (8 μM) and ZapE (8 μM), incubated for 5 min with ATP (4 mM), GTP (1.5 mM)
added after 5 min baseline, and reactions were monitored by 90° light scattering for 40
min, as described in Methodology. (B and C) Protein filter retention assays, as described
in Methodology, involving reactions of (B) ZapE (5 μM) and/or Gfp-FtsZ (10 μM), ATP
(4 mM), with or without GTP (2 mM), where indicated, and (C) ZapE(K84A) and/or
Gfp-FtsZ (10 μM), with ATP (4 mM), comparing the percentage of ZapE retained after
100-kDA filtration analyzed by SDS-PAGE and quantified by densitometry. (D) ATP
hydrolysis assay of ZapE (12 μM), FtsZ (6 μM), or ZapE (12 μM) and FtsZ (6 μM),
with ATP (4 mM), represented by pmol Pi min-1 pmol-1. Data shown in (B and C) is
representative of four, (D) three, replicates, and (B, C, and D) are represented as mean
± SEM. (p-values are as follows, ‘*’ < 0.05 and ‘****’ < 0.0001).
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FIG S3 Growth of MG1655 and MG1655 mutant strains under near optimal conditions.
MG1655, MG1655 DzapE, MG1655 DzapE::zapE, and MG1655 DzapE::zapE(K84A)
cultures were grown aerobically overnight in LB(Lennox) media at 30 °C. The next day
cultures were standardized to an OD600 of 0.05 and then grown for 3 h at 35 °C in
LB(Lennox) media, as described in Methodology. After the allotted time, culture OD600
was measured. Data from three replicates are shown as mean ± SEM.
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FIG S4 Biomass of MG1655 and mutant MG1655 strains. Dilution (2-log) of cultures
MG1655, MG1655 ΔzapE, MG1655 ΔminC, MG1655 ΔminC ΔzapE, MG1655 ΔminC
ΔzapE::zapE(K84A) and MG1655 ΔminC ΔzapE::zapE were spotted (5 μl) on LB agar
and grown under optimal conditions, as described in Methodology. (A) Plates were
incubated for 45 h at room temperature and images were taken. (B and C) MG1655 and
MG1655 mutant cultures were grown under (B) optimal or (C) mild heat shock
conditions, as described in Methodology, and OD600 measured. Data from at least three
replicates are shown as (B and C) mean ± SEM or (A) a representative image.
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Introduction

Most urinary tract infections (UTIs) are caused by Uropathogenic Escherichia
coli (UPEC) (1–3). Recently, it has been reported that UPEC possess the ability to enter
into a dormant or quiescent state at low plating density on specialized medium (4, 5).
This state is thought to mimic the quiescent intracellular reservoirs seen during UPEC
infection of bladder epithelial cells where cells are thought to become more resistant to
the host immune response and less sensitive to antibiotics (6, 7). UPEC dormancy is
thought to be the primary cause for recurrent UTIs, which plagues 27% of patients
within a year after effective antibiotic treatment (1–3).

Previously, during a mini-transposon (Tn5) mutagenesis screen in UPEC strain
CFT073, which enters quiescent state when plated on glucose minimal agar at low
population density, transposon insertions in five central carbon metabolism genes (sdha,
gnd, pykf, zwf, and gdha) reversed quiescence. These results suggest that quiescent cells
are metabolically active and require a complete tricarboxylic acid cycle; however, no
regulator was identified (4). To identify novel genes associated with supporting UPEC
quiescence, we optimized the previously published transposon mutagenesis screening
method to enhance throughput and isolated 42 mutant strains that are defective for
quiescence (4).
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Methods, Results, and Analysis
High-throughput screening for quiescence mutants. E. coli ATM161 was used as a
donor strain carrying the suicide vector pUT, possessing the mini-Tn5 kanamycin (Km)
transposon, and conjugation was performed with recipient strain CFT073, which is
streptomycin resistant, as described previously (4). Both the donor and recipient strain
were grown overnight, in LB (Lennox) media at 30 °C, shacking. The next day, 100 μL
aliquots of each culture were mixed in 5 mL of 10 mM MgSO4 and filtered through a
0.45 μm nitrocellulose membrane filter, which was subsequently placed on top of a
LB(Lennox) agar plate and incubated for 5 h at 37 °C. Filters were removed after the
allotted time and cells were resuspended in 1 mL glucose M9 minimal media. Cells
were centrifuged at 3,000 x g for 5 min and washed 2 times with glucose M9 minimal
media. Resuspended cells were then diluted and 100 μL of both 104 or 105 CFU/mL
were spread plated onto glucose M9 minimal agar with streptomycin (100 μg/mL) and
kanamycin (50 μg/mL) and incubated at 37 °C for 30 h. Individual colonies,
representing potential CFT073 non-quiescent transposon insertional mutants, were
isolated and toothpicked onto glucose M9 minimal agar with streptomycin (100 μg/mL)
and kanamycin (50 μg/mL), and were grown overnight at 37 °C. The next day colonies
were toothpicked onto LB (Lennox) agar with or without ampicillin (100 μg/mL) and
were grown overnight at 37 °C. Colonies that grew on LB(Lennox) agar and
demonstrated ampicillin sensitivity, were isolated, cultured, and frozen. Briefly, our
workflow is described in Fig. 1.
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Identification of zapE. We screened approximately 40,000 CFT073 mini-Tn5 (Km)
mutant strains, and then isolated 42 mutant strains (ECD01 - ECD42) that are defective
for quiescence1. Of relevance, in mutant strain ECD07, a transposon insertion was
identified through arbitrary PCR, as described previously (4), in the zapE gene, which
encodes the cell division regulator ZapE. ZapE is an AAA+ ATPase reported to
modulate FtsZ polymer dynamics (see Manuscript III, pp. 139) (8). To confirm the
validity of zapE as a quiescence regulator, we deleted zapE from CFT073 by lambda
red recombineering and subsequently tested if CFT073 DzapE::kan is defective for
quiescence (Fig. 2). Briefly, CFT073 and CFT073 DzapE::kan were seeded at low
density (104 cells per plate) in glucose minimal agar and incubated. After incubation for
24 h at 37 °C, we observed that CFT073 remained in a quiescent state and no colonies
had formed, while the zapE deletion strain was non-quiescent with robust colony
formation (Fig. 2). To further test if deletion of zapE is the cause of reversing
quiescence, we tested if quiescence could be restored through complementation. We
cloned zapE and zapE(K84A), encoding a ZapE mutant protein that is defective for ATP
hydrolysis [ZapE(K84A)] (see Manuscript III, pp. 138) (8), into pBad24, which contains
an arabinose inducible promoter2, and tested if the plasmids restored quiescence of
CFT073 DzapE::kan. We observed that quiescence was restored in CFT073 DzapE::kan
cells containing the zapE expression plasmid (pZapE) on glucose minimal agar;

1

CFT073 mini-transposon (Tn5) mutant strains (ECD01 – ECD42) were generated
and isolated by E. DiBiasio and sequenced for transposon insertion location by J.
Morrison.
2

Expression plasmids pZapE and pZapE(K84A) were constructed by J. Morrison and
confirmed by direct sequencing.
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however, CFT073 DzapE::kan cells with a plasmid containing zapE(K84A)
(pZapE(K84A)), are defective for quiescence, as observed through colony formation
(Fig. 2). Together, these results suggest that in CFT073, ZapE is necessary for the entry
into and/or maintenance of the quiescent state. Furthermore, although ZapE ATP
hydrolysis is not required for binding to FtsZ in vitro, it is important for maintaining the
quiescent state in UPEC.

Discussion

In conclusion, our novel transposon screen was effective at identifying a positive
regulator of UPEC quiescence. Interestingly, the regulator identified, was the cell
division regulator, ZapE. ZapE was previously shown to be involved with regulating
FtsZ polymer dynamics, and disruption or lack of ZapE in E. coli MG1655, a K-12
laboratory strain, leads to a cell division defect (8) (see Manuscript III, pp. 142).
Quiescent CFT073 cells have been reported to be filamentous and a significant
population of cells contain one or more incomplete septa (5). In addition, fluorescent
microscopy elucidated that Gfp-FtsZ ring assembly was altered or mostly nonexistent
(only present in 5% of cells) in CFT073 quiescent cells, and nucleoids were not properly
segregated (data not shown) Together, these results suggest that quiescent cells
experience a division block, which may be mediated by ZapE. While additional
experiments will be required to elucidate how ZapE functions during quiescence, there
are several models that could explain the mechanism, including: (1) ZapE may directly
induce FtsZ disassembly in vivo and destabilize the Z-ring, (2) ZapE may bundle FtsZ
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polymers and prevent Z-ring subunit turnover and/or reestablishment of the ring prior to
the next division cycle, (3) ZapE may bind to unassembled FtsZ and prevent
polymerization, or (4) ZapE may function through an unknown regulator of quiescence
that is independent of the interaction with FtsZ.
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Fig. 1: Novel approach to screen for regulators of CFT073 quiescence
Conjugation was performed between the donor strain, E. coli ATM161, containing the
mini-Tn5 suicide vector, and the recipient strain, CFT073. After mating, cells were
resuspended, washed, diluted, and spread plated onto selective agar (glucose M9 with
streptomycin (100 μg/mL) and kanamycin (50 μg/mL). Dilution CFU (104, 105) was
determined based upon population density required for the establishment of CFT073
quiescence. Colonies that formed, represented potential inactivated positive quiescent
regulatory genes, and thus, were toothpicked for isolation onto LB agar (Lennox) with
or without ampicillin (100 μg/mL). Ampicillin sensitive colonies that grew on LB
without ampicillin, were then sequenced by arbitrary PCR to identify genetic placement
of transposon insertion.
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Fig. 2. ZapE enzymatic function is required for CFT073 quiescence
CFT073 and CFT073 DzapE::kan cells were plated on M9 minimal agar with 0.2%
glucose at 104 CFU. CFT073 DzapE::kan was complemented with pZapE,
pZapE(K84A), or pBad24 and challenged in the quiescence assay at 104 CFU on M9
minimal agar with 0.2% glucose supplemented with Amp (50 μg/ml) and 0.1%
arabinose. Establishment of quiescence is determined by lack of colony formation.
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